Original Article

Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term Dialysis

Charles A. Herzog, M.D., Jennie Z. Ma, Ph.D., and Allan J. Collins, M.D.

N Engl J Med 1998; 339:799-805September 17, 1998DOI: 10.1056/NEJM199809173391203

Abstract

Background

Cardiovascular disease is common in patients on long-term dialysis, and it accounts for 44 percent of overall mortality in this group. We undertook a study to assess long-term survival after acute myocardial infarction among patients in the United States who were receiving long-term dialysis.

Full Text of Background...

Methods

Patients on dialysis who were hospitalized during the period from 1977 to 1995 for a first myocardial infarction after the initiation of renal-replacement therapy were retrospectively identified from the U.S. Renal Data System data base. Overall mortality and mortality from cardiac causes (including all in-hospital deaths) were estimated by the life-table method. The effect of independent predictors on survival was examined in a Cox regression model with adjustment for existing illnesses.

Full Text of Methods...

Results

The overall mortality (±SE) after acute myocardial infarction among 34,189 patients on long-term dialysis was 59.3±0.3 percent at one year, 73.0±0.3 percent at two years, and 89.9±0.2 percent at five years. The mortality from cardiac causes was 40.8±0.3 percent at one year, 51.8±0.3 percent at two years, and 70.2±0.4 percent at five years. Patients who were older or had diabetes had higher mortality than patients without these characteristics. Adverse outcomes occurred even in patients who had acute myocardial infarction in 1990 through 1995. Also, the mortality rate after myocardial infarction was considerably higher for patients on long-term dialysis than for renal-transplant recipients.

Full Text of Results...

Conclusions

Patients on dialysis who have acute myocardial infarction have high mortality from cardiac causes and poor long-term survival.

Full Text of Discussion...

Read the Full Article...

Media in This Article

Figure 1Estimated Cumulative Mortality after Acute Myocardial Infarction among Patients on Dialysis.

Table 1Overall Rate of Death and Rate of Death from Cardiac Causes after Acute Myocardial Infarction among Patients on Dialysis, According to Age and Cause of Renal Failure, 1977 through 1995.

Article Activity

326 articles have cited this article

Article

Cardiac disease is the single most important cause of death among patients receiving long-term dialysis therapy, accounting for 44 percent of overall mortality.1 Approximately 22 percent of these deaths from cardiac causes are attributed to acute myocardial infarction. For the period from 1993 through 1995, the adjusted overall death rate for patients on dialysis was 243 deaths per 1000 patient-years.1 The risks of death from cardiac causes and of death from all causes are higher among older patients, those with diabetic nephropathy, and those receiving peritoneal dialysis.1 Thus, there is an increasing burden of cardiac disease in patients on long-term dialysis, since the greatest increase in end-stage renal disease treated with dialysis has occurred in older patients and those with diabetic renal failure. The mortality rate from 1993 through 1995 for patients 65 years of age or more with diabetic end-stage renal disease was 368 deaths per 1000 patient-years, with cardiac disease accounting for 46 percent of overall mortality.2 In 1995 approximately 200,000 patients received dialysis in the United States; 18 percent of them received peritoneal dialysis, and 82 percent received hemodialysis.3

Despite the burden of cardiac disease among patients on dialysis, there are no published data on their long-term survival after acute myocardial infarction. The purpose of our study was to estimate the long-term survival of patients in the U.S. who were receiving dialysis and who had acute myocardial infarction. Using the U.S. Renal Data System data base4 of 627,983 patients (approximately three fourths of whom were on dialysis and one fourth of whom were renal-transplant recipients), we examined the outcome after a first acute myocardial infarction for 34,189 patients on long-term dialysis.

Methods

All data were derived from the U.S. Renal Data System, which includes data on approximately 92 percent of all patients undergoing dialysis in the United States.5 The accuracy of these data has been validated previously.6

The study was a retrospective analysis of patients undergoing dialysis who were hospitalized for a first (index) acute myocardial infarction that occurred after the initiation of renal-replacement therapy from January 1977 to June 1995. The patients identified from the data base of 627,983 patients were those who had code 410, 410.X, 410.X0, or 410.X1 of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).7 Eligible patients had received renal-replacement therapy for a total of at least 90 days and dialysis for at least 60 days before having an acute myocardial infarction. Demographic data on the patients included age, sex, race or ethnic group (Hispanic patients were not identified in the data base), calendar year of infarction, and primary renal diagnosis.

The effect of coexisting conditions was examined, since comorbidity significantly influences the survival of patients on dialysis.8-10 We used a previously developed comorbidity-profiling method based on ICD-9-CM diagnosis and procedure codes in Medicare Part A institutional inpatient claims. Coexisting conditions were identified by ICD-9-CM codes from hospitalizations that occurred before the index acute myocardial infarction. Coexisting conditions included congestive heart failure, other cardiac conditions (including valvular heart disease, implantation of a pacemaker, and arrhythmia), cancers other than skin cancer, peripheral vascular disease, cerebrovascular ischemia (which included cerebrovascular accident and transient ischemic attack), chronic obstructive pulmonary disease, gastrointestinal disease, gallbladder disease, and liver disease. Previous coronary revascularization (coronary bypass surgery or coronary angioplasty) was analyzed separately in the Cox proportional-hazards model.

In-hospital mortality and the number of deaths per 1000 patient-years were estimated. Survival time was calculated from the date of admission to the hospital for acute myocardial infarction to the date on which the data were censored or on which an end point (including in-hospital death) was reached. If a patient on dialysis had more than one infarction, the first was analyzed as the index event. The study end points were death from cardiac causes and death from any cause (including early in-hospital death). The data were censored if a patient underwent renal transplantation, was still alive at the end of the study, or was lost to follow-up.

Long-term survival and mortality were estimated by the life-table method.11 The log-rank test was used to compare cumulative survival in different groups. A Cox proportional-hazards model was used to evaluate the effect of independent predictors (demographic characteristics, coexisting illnesses, and duration of end-stage renal disease before acute myocardial infarction) on patients' survival.12 The reported P values in the Cox model are based on the Wald test. All reported P values are two-sided. Statistical analyses were performed with use of the SAS system for Windows, version 6.12 (SAS Institute, Cary, N.C.).

A parallel survival analysis of renal-transplant recipients with acute myocardial infarction was performed by the life-table method. The survival of patients on dialysis was compared with that of transplant recipients in a Cox model.

The Human Subject Research Committee of the Hennepin County Medical Center institutional review board approved this study.

Results

There were 34,189 patients on dialysis who had acute myocardial infarction. The mean follow-up after myocardial infarction was 1.16 years (interquartile range [25th to 75th percentile], 0.05 to 1.59). There were 858 patients lost to follow-up.

Demographic Characteristics

Fifty-six percent of the group were men, and 44 percent were women. Eight percent were 44 years of age or less, 37 percent were 45 to 64 years old, 35 percent were 65 to 74 years old, and 20 percent were 75 or more years old. Seventy-one percent were white, 25 percent black, 1 percent Native American, 2 percent Asian, and 1 percent of other ethnic groups. The cause of renal failure was diabetes in 34 percent, hypertension in 30 percent, and other conditions in 36 percent. Ten percent of acute myocardial infarctions occurred from 1977 through 1984, 30 percent from 1985 through 1989, and 60 percent from 1990 through 1995.

There were 3079 renal-transplant recipients with acute myocardial infarction. For these patients, the mean follow-up after myocardial infarction was 2.46 years. Seventy-two percent of the patients were men, and 28 percent were women. Thirty-four percent were 44 years of age or less, 55 percent were 45 to 64 years old, 10 percent were 65 to 74 years old, and 1 percent were 75 or more years old. Eighty-four percent were white, 14 percent were black, and 2 percent were of other races or ethnic groups. The cause of renal failure was diabetes in 31 percent, hypertension in 14 percent, and other conditions in 55 percent. Six percent of acute myocardial infarctions occurred from 1977 through 1984, 30 percent from 1985 through 1989, and 64 percent from 1990 through 1995.

We examined the temporal pattern of occurrence of acute myocardial infarction in relation to the duration of dialysis. There appeared to be an early hazard of myocardial infarction related to the initiation of dialysis, since 29 percent of infarctions occurred within one year and 52 percent within two years after the initiation of dialysis. In renal-transplant recipients, 15 percent of infarctions occurred within one year after transplantation and 29 percent within two years.

Mortality

Patients Undergoing Dialysis

The estimated in-hospital mortality for the entire cohort of patients on dialysis who had acute myocardial infarction was 26 percent. Twenty-one percent of patients under 65 years of age and 30 percent of those 65 or more years of age died in the hospital. Twenty-seven percent of all patients with diabetic end-stage renal disease and 30 percent of those 65 or more years of age died in the hospital.

Table 1Table 1Overall Rate of Death and Rate of Death from Cardiac Causes after Acute Myocardial Infarction among Patients on Dialysis, According to Age and Cause of Renal Failure, 1977 through 1995. summarizes the rates of death from all causes and from cardiac causes according to age and cause of renal failure. An age of 65 years or more was a powerful predictor of death after acute myocardial infarction. Patients in this age group who had diabetic end-stage renal disease had an average life expectancy of less than one year after myocardial infarction.

The curves for death from cardiac causes and death from all causes are shown in Figure 1Figure 1Estimated Cumulative Mortality after Acute Myocardial Infarction among Patients on Dialysis.. Most patients on dialysis who had acute myocardial infarctions ultimately died of heart disease.

Table 2Table 2Estimated Cumulative Overall Mortality and Mortality from Cardiac Causes after Acute Myocardial Infarction among Patients with End-Stage Renal Disease, According to Cause of Renal Failure and Year of Occurrence of Acute Myocardial Infarction. summarizes estimated long-term mortality from all causes and from heart disease according to renal diagnosis and the year of occurrence of acute myocardial infarction. Patients on dialysis who had diabetic end-stage renal disease had the highest mortality both overall and from cardiac causes. Surprisingly, the patients who had had acute myocardial infarctions most recently (between 1990 and 1995) had a higher overall rate of death from all causes than those who had had myocardial infarctions between 1977 and 1984 or between 1985 and 1989 (P<0.001). The trends were similar for death from cardiac causes.

The effects of independent predictors of overall mortality and mortality from cardiac causes were examined by the Cox proportional-hazards model. Table 3Table 3Results of Cox Proportional-Hazards Model of Death from All Causes. summarizes independent predictors of overall mortality. The most powerful predictors of overall mortality were older age and the presence of diabetic end-stage renal disease. Coexisting noncardiac conditions (except gallbladder disease) independently increased the risk of death by 10 to 19 percent according to the Cox model. The duration of end-stage renal disease, however, did not independently affect survival. Thus, the time from the initiation of dialysis to the index acute myocardial infarction was not an independent predictor of survival. Previous coronary revascularization was associated with a 13 percent reduction in risk. Female sex was associated with a small survival advantage (relative risk of death, 0.96; 95 percent confidence interval, 0.94 to 0.99). Race was a more powerful predictor of survival, since nonwhite patients had better outcomes. As compared with whites, black patients had a relative risk of death of 0.82 (95 percent confidence interval, 0.80 to 0.85).

Table 4Table 4Results of Cox Proportional-Hazards Model of Death from Cardiac Causes. summarizes independent predictors of mortality from cardiac causes. Older age and the presence of diabetic end-stage renal disease were the most powerful predictors of mortality, and noncardiac coexisting conditions had a small effect. Previous congestive heart failure was associated with a relative risk of death from cardiac causes of 1.22 (95 percent confidence interval, 1.18 to 1.26). There was a reduced risk of death from cardiac causes after myocardial infarction for women (relative risk, 0.92; 95 percent confidence interval, 0.89 to 0.95). Race was a predictor of improved survival for all nonwhite patient groups. As compared with whites, black patients had a relative risk of death from cardiac causes of 0.81 (95 percent confidence interval, 0.78 to 0.84). Previous coronary revascularization was associated with a 10 percent reduction in risk.

The somewhat counterintuitive effect on survival of the time of occurrence of acute myocardial infarction is partly explained by the Cox model. According to the Cox model, patients who had more recent myocardial infarctions (those occurring between 1985 and 1989 or between 1990 and 1995) had better survival than those who had myocardial infarctions earlier (1977 to 1984). For patients with myocardial infarctions between 1990 and 1995, the relative risk of death from all causes was 0.87 (95 percent confidence interval, 0.83 to 0.90) and that of death from cardiac causes was 0.83 (95 percent confidence interval, 0.78 to 0.88). These results indicate that there has been a recent improvement in survival after adjustment is made for comorbidity.

Renal-Transplant Recipients

The estimated in-hospital mortality was 11.5 percent for the entire cohort of renal-transplant recipients. Table 2 includes selected mortality data for renal-transplant recipients with acute myocardial infarction.

Dialysis versus Transplantation

Large differences in mortality between patients on dialysis and renal-transplant recipients persisted after adjustment for demographic characteristics, cause of renal failure, duration of end-stage renal disease, calendar year of occurrence of acute myocardial infarction, and coexisting illnesses. The relative risk of death from all causes for patients undergoing dialysis as compared with renal-transplant recipients was 2.74 (95 percent confidence interval, 2.57 to 2.91). The relative risk of death from cardiac causes was 4.45 (95 percent confidence interval, 4.01 to 4.94). These results should be interpreted cautiously, because even after adjustment, patients undergoing dialysis and renal-transplant recipients may not be completely comparable.

Discussion

There are few data on long-term survival after acute myocardial infarction among patients on dialysis. Two preliminary reports suggested increased in-hospital mortality (29 percent and 33 percent) for these patients.13,14 In this study we have shown that acute myocardial infarction in patients on dialysis is a catastrophic event associated with dismal long-term survival. For the entire cohort of 34,189 patients on dialysis who had acute myocardial infarctions from 1977 to 1995, only 41 percent of patients survived for one year and 27 percent for two years. Even more striking was the poor survival of patients treated in the era of reperfusion. Patients who had acute myocardial infarctions from 1990 to 1995 had overall mortality rates of 61 percent at one year and 74 percent at two years. The two-year mortality from cardiac causes was about 50 percent in patients who had acute myocardial infarctions from 1977 to 1984 and 52 percent for those who had acute myocardial infarctions from 1990 to 1995. The high mortality from cardiac disease and even higher overall mortality probably reflect the effects of coexisting conditions,8,15 but it is unclear how much of the difference of approximately 20 percentage points between overall mortality and mortality from cardiac causes at two years is attributable to coexisting conditions. The persistently poor outcomes over time mask a small improvement in survival adjusted for comorbidity in the Cox model. There was a 13 percent reduction in the risk of death from all causes and a 17 percent reduction in the risk of death from cardiac causes in 1990 to 1995, as compared with 1977 to 1984. This masking is explainable by the increase in the proportion of older patients and patients with diabetes over time, which contributed to increased mortality.

The survival of patients on dialysis who had acute myocardial infarctions is considerably worse than would be expected on the basis of other published reports of patients without end-stage renal disease who had acute myocardial infarctions, including patients with other coexisting conditions. The most powerful independent predictors of overall mortality and mortality from cardiac causes in our study were older age and diabetic nephropathy, but even patients with end-stage renal disease that was not due to diabetes or hypertension had poor outcomes, with a 31 percent two-year survival (69 percent overall mortality). In diabetic patients without end-stage renal disease who had acute myocardial infarction, a one-year survival of 80 percent16 and a 19-month survival of 75 percent17 were reported in the era before reperfusion therapy became common.

In the Minnesota Heart Survey, the in-hospital case fatality rate in 1985 for patients with diabetes who had acute myocardial infarction was 18 percent in men and 16 percent in women.18 Over the period from 1970 to 1985, about three fourths of diabetic men and two thirds of diabetic women who were discharged after an acute myocardial infarction were still alive two years later.18 In the Worcester Heart Attack Study, the overall in-hospital case fatality rate after myocardial infarction was 22 percent for diabetic patients for the period from 1975 to 1986. Approximately three fourths of diabetic men and two thirds of diabetic women discharged after an acute myocardial infarction were still alive two years later.19 In the Minnesota Heart Survey, the three-year survival rate after acute myocardial infarction ranged from 63.5 percent to 73.1 percent for men and from 60.6 percent to 66.9 percent for women from 1970 to 1985,20 with an additional reduction in mortality in 1990.21 In the present study, 60 percent of all patients on dialysis between 1990 and 1995 had acute myocardial infarctions. The substantial reduction in mortality from acute myocardial infarction over time that was observed in the Minnesota Heart Survey has not been mirrored in the population undergoing dialysis.

There appears to be greater mortality from cardiac causes and greater overall mortality among patients on dialysis who have acute myocardial infarctions than among another cohort of patients with end-stage renal disease, renal-transplant recipients who have myocardial infarctions. The two-year mortality from cardiac causes of 11.4 percent and overall mortality of 30.4 percent in the renal-transplant cohort are more favorable than the two-year mortality from cardiac causes of 51.8 percent and overall mortality of 73.0 percent among the patients undergoing dialysis. This difference in mortality is apparent at all times from 1 to 10 years.

Our finding that mortality after acute myocardial infarction among patients on dialysis is lower for blacks than for whites is consistent with previously published data on the survival of patients on dialysis. In 1984 the one-year death rate of white patients on dialysis was higher than that of black patients by 13 deaths per 100 patient-years.22 By 1994 this difference had narrowed to 5 deaths per 100 patient-years.22 Bloembergen et al.23 reported that white patients had a 29 percent higher risk of death than blacks and that whites were 34 percent more likely to die of myocardial infarction. In the present study, the overall risk of death after myocardial infarction for patients on dialysis was 18 percent lower for blacks than for whites, and the risk of death from cardiac disease was 19 percent lower.

We found a small advantage in terms of survival after acute myocardial infarction associated with female sex, with a 4 percent reduction in overall mortality and an 8 percent reduction in mortality due to cardiac disease. Although female sex has usually been associated with higher mortality from acute myocardial infarction among patients without end-stage renal disease, a recent study disputes earlier reports of excess early mortality in women.24

Our data suggest that there is an early risk of acute myocardial infarction associated with the initiation of dialysis, with 29 percent of infarctions occurring within one year and 52 percent occurring within two years after the initiation of dialysis. Usually patients with end-stage renal disease are evaluated for risk of cardiac events only when they are being considered for renal transplantation. We suggest that an evaluation for cardiac risk be considered for such patients at the initiation of dialysis.

There are several limitations to our study. The primary source of the U.S. Renal Data System data was Medicare claims data, which may be subject to inaccuracies in the diagnosis of acute myocardial infarction. After comparing claims data with medical-chart (clinical) data in a study of 12,937 patients undergoing inpatient cardiac catheterization, Jollis et al.25 found an 88 percent rate of agreement between claims data and clinical data with respect to the ICD-9-CM code for acute myocardial infarction (410), with a specificity of 95 percent.25 We undoubtedly missed some patients with acute myocardial infarction, since Jollis et al. found that claims data had 76 percent sensitivity as compared with clinical data for the diagnosis of acute myocardial infarction.25

Two aspects of our methods may have led to an underestimation of mortality. Our survival analysis ignored out-of-hospital deaths from acute myocardial infarction and those occurring less than 60 days after the initiation of dialysis. The issue of “missed” or “uncounted” acute myocardial infarctions makes accurate estimation of the incidence of acute myocardial infarction difficult, but our data indicate that in 1995 there were at least 5000 first-time infarctions after the initiation of dialysis, with 1300 in-hospital deaths, in a population of 200,000 patients on dialysis. The total number of acute myocardial infarctions and resulting in-hospital deaths may be considerably larger, since in our study, survival analysis was restricted to the first (index) acute myocardial infarction. On the basis of data from the U.S. Renal Data System, approximately 4600 deaths per year (not restricted to in-hospital deaths) in 200,000 patients on dialysis are attributed to acute myocardial infarction.1 The principal weakness of the data base is that it provides few clinical data. Therefore, important prognostic factors, such as the left ventricular ejection fraction and hemodynamic data, were not available for our study.

The present study does not explain the persistence of poor survival rates after acute myocardial infarction over time, even in the reperfusion era. Preliminary data from an ongoing study suggest that thrombolytic therapy is underused in the treatment of patients on dialysis who have acute myocardial infarction,26 but there are no published data on the survival of patients on dialysis who receive reperfusion therapy for acute myocardial infarction.

We conclude that patients on dialysis who have acute myocardial infarction have high rates of death from cardiac causes and poor long-term survival. Our data provide support for the development of more aggressive strategies for the prevention and treatment of acute myocardial infarction in patients on dialysis.

Supported by a grant (1 RO1 DK 49540) from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md.

The data reported here have been supplied by the U.S. Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the U.S. government.

Source Information

From the Divisions of Cardiology (C.A.H.) and Nephrology (J.Z.M., A.J.C.), Department of Internal Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis.

Address reprint requests to Dr. Herzog at the Hennepin County Medical Center, 701 Park Ave., Minneapolis, MN 55415.

References

References

1. 1

   Renal Data System. USRDS 1997 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, April 1997:91-101. (NIH publication no. 97-3176.)
   

2. 2

   Renal Data System. USRDS 1997 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, April 1997:D1-D51. (NIH publication no. 97-3176.)
   

3. 3

   Renal Data System. USRDS 1997 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, April 1997:35-47. (NIH publication no. 97-3176.)
   

4. 4

   Renal Data System. USRDS 1997 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, April 1997:C1-C41. (NIH publication no. 97-3176.)
   

5. 5

   Renal Data System. USRDS 1997 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, April 1997:21-48. (NIH publication no. 97-3176.)
   

6. 6

   Renal Data System. USRDS 1992 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, August 1992:61-82. (NIH publication no. 92-3176.)
   

7. 7

   Puckett CD. The educational annotation of ICD-9-CM. 4th ed. 6th printing. Vols. 1, 2, 3. Reno, Nev.: Channel Publishing, 1997.
   

8. 8

   Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994;24:1010-1018
   Web of Science | Medline

9. 9

   Gaylin DS, Held PJ, Port FK. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 1993;269:603-608
   CrossRef | Web of Science | Medline

10. 10

    Held PJ, Port FK, Gaylin DS, et al. Evaluations of initial predictors of mortality among 4387 new ESRD patients: the USRDS case mix study. J Am Soc Nephrol 1991;2:328-328 abstract.
    

11. 11

    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
    CrossRef | Web of Science

12. 12

    Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-202
    

13. 13

    Rubin TA, Thielen KA, Collins AJ, Herzog CA. Acute myocardial infarction in chronic dialysis patients. J Am Coll Cardiol 1996;27:Suppl A:67A-67A abstract.
    CrossRef

14. 14

    Kong TQ, Dacanay S, Hsieh AA. Features of acute myocardial infarction in patients on chronic hemodialysis. Circulation 1993;88:Suppl I:I-49 abstract.
    

15. 15

    Collins AJ, Hanson G, Umen A, Kjellstrand C, Keshaviah P. Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis 1990;25:422-432
    

16. 16

    Nicod P, Gilipin E, Dittrich H, et al. Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation 1989;79:528-536
    CrossRef | Web of Science | Medline

17. 17

    Smith JW, Marcus FI, Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 1984;54:718-721
    CrossRef | Web of Science | Medline

18. 18

    Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival: the Minnesota Heart Survey. Diabetes Care 1991;14:537-543
    CrossRef | Web of Science | Medline

19. 19

    Donahue RP, Goldberg RJ, Chen Z, Gore JM, Alpert JS. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective. J Clin Epidemiol 1993;46:245-252
    CrossRef | Web of Science | Medline

20. 20

    McGovern PG, Folsom AR, Sprafka JM, et al. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985: the Minnesota Heart Survey. Circulation 1992;85:172-179
    Web of Science | Medline

21. 21

    McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-890
    Free Full Text | Web of Science | Medline

22. 22

    Renal Data System. USRDS 1997 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, April 1997:69-89. (NIH publication no. 97-3176.)
    

23. 23

    Bloembergen WE, Port FK, Mauger EA, Wolfe RA. Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol 1994;5:1231-1242
    Web of Science | Medline

24. 24

    Malacrida R, Genoni M, Maggioni AP, et al. A comparison of the early outcome of acute myocardial infarction in women and men. N Engl J Med 1998;338:8-14
    Free Full Text | Web of Science | Medline

25. 25

    Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med 1993;119:844-850
    Web of Science | Medline

26. 26

    Herzog CA, Ma J, Collins AJ. Outcome of dialysis patients receiving thrombolytic therapy for acute myocardial infarction (AMI) in the United States. Circulation 1997;96:Suppl I:I-202 abstract.
    

Citing Articles (326)

Citing Articles

1. 1

   David M. Charytan, Pallav Garg, Manu Varma, Michael S. Garshick, Cathy Jeon, Laura Mauri. (2013) Angiographic characteristics of coronary arterial segments progressing to myocardial infarction in patients with and without chronic kidney disease. Clinical and Experimental Nephrology 17:2, 232-239
   

2. 2

   A. Rangel-Lopez, M. E. Paniagua-Medina, M. Urban-Reyes, M. Cortes-Arredondo, C. Alvarez-Aguilar, J. Lopez-Meza, A. Ochoa-Zarzosa, B. Lindholm, E. Garcia-Lopez, J. R. Paniagua. (2013) Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study. Mutagenesis 28:2, 219-225
   

3. 3

   Gulgun S. Guven, Mehmet R. Altiparmak, Sinan Trabulus, Ayse S. Yalin, Bahadir Batar, Aydin Tunckale, Mehmet Guven. (2013) Relationship Between Genomic Damage and Clinical Features in Dialysis Patients. Genetic Testing and Molecular Biomarkers 17:3, 202-206
   

4. 4

   Mark R. Kahn, Michael J. Robbins, Michael C. Kim, Valentin Fuster. (2013) Management of cardiovascular disease in patients with kidney disease. Nature Reviews Cardiology 10:5, 261-273
   

5. 5

   Tzu-Hsien Tsai, Kuo-Ho Yeh, Cheuk-Kwan Sun, Cheng-Hsu Yang, Shyh-Ming Chen, Chi-Ling Hang, Chien-Jen Chen, Sheng-Ying Chung, Yung-Lung Chen, Chiung-Jen Wu, Hsuen-Wen Chang, Hon-Kan Yip. (2013) Estimated Glomerular Filtration Rate as a Useful Predictor of Mortality in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. The American Journal of the Medical Sciences 345:2, 104-111
   

6. 6

   Yen-Ta Chen, Ben-Chung Cheng, Sheung-Fat Ko, Chih-Hung Chen, Tzu-Hsien Tsai, Steve Leu, Hsueh-Wen Chang, Sheng-Ying Chung, Sarah Chua, Kuo-Ho Yeh, Yung-Lung Chen, Hon-Kan Yip. (2013) Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease. Clinical and Experimental Nephrology 17:1, 83-91
   

7. 7

   Markus P. Schlaich, Bradley Bart, Dagmara Hering, Anthony Walton, Petra Marusic, Felix Mahfoud, Michael Böhm, Elisabeth A. Lambert, Henry Krum, Paul A. Sobotka, Roland E. Schmieder, Carolina Ika-Sari, Nina Eikelis, Nora Straznicky, Gavin W. Lambert, Murray D. Esler. (2013) Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. International Journal of Cardiology
   

8. 8

   Dharam J. Kumbhani, Gregg C. Fonarow, Christopher P. Cannon, Adrian F. Hernandez, Eric D. Peterson, W. Frank Peacock, Warren K. Laskey, Wenqin Pan, Lee H. Schwamm, Deepak L. Bhatt. (2013) Predictors of Adherence to Performance Measures in Patients with Acute Myocardial Infarction. The American Journal of Medicine 126:1, 74.e1-74.e9
   

9. 9

   Leonardo Pinto de Carvalho, Peter A. McCullough, Fei Gao, Ling Ling Sim, Huay Cheem Tan, David Foo, Yau Wei Ooi, A. Mark Richards, Mark Y. Chan, Tiong-Cheng Yeo. (2013) Renal function and anaemia in acute myocardial infarction. International Journal of Cardiology
   

10. 10

    Michio Kuwahara, Junichi Ishigami, Satomi Shikuma, Wataru Akita, Yoshihiro Mori, Tomoki Asai, Yusuke Tsukamoto, Susumu Adachi, Yumi Noda, Tatemitsu Rai, Shinichi Uchida, Sei Sasaki. (2012) Type II Diabetes Mellitus Is a Risk Factor for Heart Failure in Pre-Dialysis Patients. Therapeutic Apheresis and Dialysis 16:6, 541-547
    

11. 11

    G. OCAK, K. J. VAN STRALEN, F. R. ROSENDAAL, M. VERDUIJN, P. RAVANI, R. PALSSON, T. LEIVESTAD, A. J. HOITSMA, M. FERRER-ALAMAR, P. FINNE, J. DE MEESTER, C. WANNER, F. W. DEKKER, K. J. JAGER. (2012) Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. Journal of Thrombosis and Haemostasis 10:12, 2484-2493
    

12. 12

    Chih-Hsuan Yen, Chung-Lieh Hung, Yih-Jer Wu, Jui-Peng Tsai, Ta-Chuan Hung, Cheng-Huang Su, Jen-Yuan Kuo, Hung-I Yeh, Cheng-Ho Tsai. (2012) Relationship between Metabolic Scores, Systemic Inflammation, Renal Function, and High-risk Peripheral Arterial Disease. International Journal of Gerontology
    

13. 13

    Sukru Ulusoy, Gulsum Ozkan, Ahmet Menteşe, Adnan Yavuz, S. Caner Karahan, Ayşegül Uzun Sümer. (2012) Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) level in hemodialysis patients and parameters affecting that level. Clinical Biochemistry 45:16-17, 1444-1449
    

14. 14

    Timothy D. Henry, Charles A. Herzog. (2012) Bad kidneys are bad for the heart: But what can we do about it?. Catheterization and Cardiovascular Interventions 80:3, 358-360
    

15. 15

    D. V. Rizk, O. Gutierrez, E. B. Levitan, W. M. McClellan, M. Safford, E. Z. Soliman, D. G. Warnock, P. Muntner. (2012) Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease. Nephrology Dialysis Transplantation 27:9, 3482-3488
    

16. 16

    Samip Vasaiwala, Christopher P. Cannon, Gregg C. Fonarow, W. Frank Peacock, Warren Laskey, Lee H. Schwamm, Li Liang, Adrian F. Hernandez, Eric D. Peterson, Sylvia E. Rosas, Deepak L. Bhatt, . (2012) Quality of Care and Outcomes Among Patients With Acute Myocardial Infarction by Level of Kidney Function at Admission: Report From the Get With The Guidelines Coronary Artery Disease Program. Clinical Cardiology 35:9, 541-547
    

17. 17

    Ming-Ting Chou, Jhi-Joung Wang, Yih-Min Sun, Ming-Jen Sheu, Chin-Chen Chu, Shih-Feng Weng, Chung-Ching Chio, Wei-Chih Kan, Chih-Chiang Chien. (2012) Epidemiology and mortality among dialysis patients with acute coronary syndrome: Taiwan National Cohort Study. International Journal of Cardiology
    

18. 18

    Silvia B. Sandoval, Susana Pastor, Elitsa Stoyanova, Lara Rodríguez-Ribera, Wilser A. García-Quispes, Elisabet Coll, Joselyn Reyes, Enrique Andrés, José Ballarin, Ricard Marcos. (2012) Genomic instability in chronic renal failure patients. Environmental and Molecular Mutagenesis 53:5, 343-349
    

19. 19

    Tsung-Jen Wang, Cho-Kai Wu, Chao-Chien Hu, Joseph J. Keller, Herng-Ching Lin. (2012) Increased Risk of Co-morbid Eye Disease in Patients with Chronic Renal Failure: A Population-based Study. Ophthalmic Epidemiology 19:3, 137-143
    

20. 20

    Tanuj Bhatia, Aditya Kapoor. (2012) Chronic kidney disease and its adverse cardiovascular associations. Clinical Queries: Nephrology
    

21. 21

    Michitaka Nagashima, Nobuhisa Hagiwara, Ryo Koyanagi, Jun-ichi Yamaguchi, Atsushi Takagi, Erisa Kawada-Watanabe, Tsuyoshi Shiga, Hiroshi Ogawa. (2012) Chronic kidney disease and long-term outcomes of myocardial infarction. International Journal of Cardiology
    

22. 22

    Sachie Terazawa, Kazuyoshi Tajima, Yoshiyuki Takami, Keisuke Tanaka, Noritaka Okada, Akihiko Usui, Yuichi Ueda. (2012) Early and Late Outcomes of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention with Drug-Eluting Stents for Dialysis Patients. Journal of Cardiac Surgery 27:3, 281-287
    

23. 23

    Surendra Kumar Agarwal, Bipin Chandra. (2012) Vascular complications in diabetic kidney disease patients. Clinical Queries: Nephrology 1:2, 178-182
    

24. 24

    Anurag Gupta. (2012) Hemodialysis in diabetics end-stage renal disease. Clinical Queries: Nephrology 1:2, 163-165
    

25. 25

    Markus P. Schlaich, Dagmara Hering, Paul A. Sobotka, Henry Krum, Murray D. Esler. (2012) Renal Denervation in Human Hypertension: Mechanisms, Current Findings, and Future Prospects. Current Hypertension Reports
    

26. 26

    J. Beimler, M. Zeier, C. Morath. (2012) Meldung von Patienten zur Transplantation. Der Nephrologe 7:2, 104-113
    

27. 27

    Gautam R. Shroff, Paul D. Frederick, Charles A. Herzog. (2012) Renal failure and acute myocardial infarction: Clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. American Heart Journal 163:3, 399-406
    

28. 28

    Salvatore P. Costa, John E. Jayne, Scott E. Friedman, Krista L. Lentine. (2012) Cardiac Catheterization in the Dialysis Population in 2012: We Know More, but Much Remains Unknown. Seminars in Dialysisno-no
    

29. 29

    M. A. C. Onuigbo. (2012) Long inter-dialytic interval and mortality among patients receiving maintenance haemodialysis for end-stage renal disease - a call for more studies on the right amount or frequency of maintenance haemodialysis for end-stage renal disease. International Journal of Clinical Practice 66:3, 327-327
    

30. 30

    Sinan Trabulus, Gulgun S. Guven, Mehmet R. Altiparmak, Bahadir Batar, Ozlem Tun, Ayse S. Yalin, Aydin Tunckale, Mehmet Guven. (2012) DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease. Molecular Biology Reports
    

31. 31

    H. Ishii, Y. Kumada, H. Takahashi, T. Toriyama, T. Aoyama, M. Tanaka, D. Yoshikawa, M. Hayashi, H. Kasuga, Y. Yasuda, S. Maruyama, T. Matsubara, S. Matsuo, T. Murohara. (2012) Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis. Diabetologia
    

32. 32

    Yasuhiko Shimoyama, Yoshinari Tsuruta, Toshimitsu Niwa. (2012) Coronary Artery Calcification Score is Associated With Mortality in Japanese Hemodialysis Patients. Journal of Renal Nutrition 22:1, 139-142
    

33. 33

    Jolanta Malyszko, Jacek S. Malyszko, Dimitri P. Mikhailidis, Jacek Rysz, Marcin Zorawski, Maciej Banach. (2012) Hypertension and kidney disease. Journal of Hypertension1
    

34. 34

    Birgit Linnemann, Thilo Sutter, Sebastian Sixt, Aljoscha Rastan, Uwe Schwarzwaelder, Elias Noory, Karlheinz Buergelin, Ulrich Beschorner, Thomas Zeller. (2012) Elevated cardiac troponin T contributes to prediction of worse in-hospital outcomes after endovascular therapy for acute limb ischemia. Journal of Vascular Surgery
    

35. 35

    GABRIEL MALUENDA, REBECCA TORGUSON, ZHENYI XUE, WILLIAM O. SUDDATH, KENNETH M. KENT, JOSEPH LINDSAY, LOWELL F. SATLER, AUGUSTO D. PICHARD, RON WAKSMAN, GABRIEL L. SARDI. (2012) Impact of Diabetes Mellitus on Long-term Clinical Outcomes of Patients on Chronic Hemodialysis after Percutaneous Coronary Intervention : DIABETES AND CHRONIC HEMODIALYSIS AFTER PCI. Journal of Interventional Cardiology 25:2, 147
    

36. 36

    Anurag Gupta. (2012) Hemodialysis in diabetics end-stage renal disease. Clinical Queries: Nephrology 1:2, 163
    

37. 37

    Surendra Kumar Agarwal, Bipin Chandra. (2012) Vascular complications in diabetic kidney disease patients. Clinical Queries: Nephrology 1:2, 178
    

38. 38

    J. Matthew Brennan, Brahmajee K. Nallamothu, Uptal D. Patel. Contrast-Induced Acute Kidney Injury and the Role of Chronic Kidney Disease in PCI. In: Textbook of Interventional Cardiology. Elsevier, 2012:66-74.
    

39. 39

    Peter A. McCullough. Interface Between Renal Disease and Cardiovascular Illness. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier, 2012:1934-1948.
    

40. 40

    Hiroyuki Imamura, Keiko Mizuuchi, Reika Oshikata. (2012) Physical Activity and Blood Lipids and Lipoproteins in Dialysis Patients. International Journal of Nephrology 2012, 1-6
    

41. 41

    Mehmet Akif Cakar, Huseyin Gunduz, Mehmet Bulent Vatan, Ibrahim Kocayigit, Ramazan Akdemir. (2012) The Effect of Admission Creatinine Levels on One-Year Mortality in Acute Myocardial Infarction. The Scientific World Journal 2012, 1-5
    

42. 42

    Nicola Tessitore, Antonio Santoro, Giovanni Oliviero Panzetta, Volker Wizemann, Rafael Perez-Garcia, Jorge Martinez Ara, Bruno Perrone, William Mantovani, Albino Poli. (2012) Acetate-Free Biofiltration Reduces Intradialytic Hypotension: A European Multicenter Randomized Controlled Trial. Blood Purification 34:3-4, 354-363
    

43. 43

    Shan Mou, Qin Wang, Wei Fang, Aiwu Lin, Beili Shi, Liou Cao, Wenyan Zhou, Jiaqi Qian, Zhaohui Ni. (2011) Change in Cardiovascular Disease Status in Peritoneal Dialysis Patients: A 5-Year Single-Center Experience. Renal Failure1-7
    

44. 44

    Dinna N. Cruz, Mihai Gheorghiade, Alberto Palazuolli, Claudio Ronco, Sean M. Bagshaw. (2011) Epidemiology and outcome of the cardio-renal syndrome. Heart Failure Reviews 16:6, 531-542
    

45. 45

    C. Medi, D. P. B. Chew, J. Amerena, S. Coverdale, A. Soman, C. Astley, J. Rankin, D. Brieger. (2011) An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease. Internal Medicine Journal 41:10, 743-750
    

46. 46

    Alan S. Go, Nisha Bansal, Malini Chandra, Phenius V. Lathon, Stephen P. Fortmann, Carlos Iribarren, Chi-yuan Hsu, Mark A. Hlatky. (2011) Chronic Kidney Disease and Risk for Presenting With Acute Myocardial Infarction Versus Stable Exertional Angina in Adults With Coronary Heart Disease. Journal of the American College of Cardiology 58:15, 1600-1607
    

47. 47

    John K. Roberts, Uptal D. Patel. (2011) Management of Coronary Artery Disease in End-Stage Renal Disease. Seminars in Dialysis 24:5, 525-532
    

48. 48

    Charles A Herzog, Richard W Asinger, Alan K Berger, David M Charytan, Javier Díez, Robert G Hart, Kai-Uwe Eckardt, Bertram L Kasiske, Peter A McCullough, Rod S Passman, Stephanie S DeLoach, Patrick H Pun, Eberhard Ritz. (2011) Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International 80:6, 572-586
    

49. 49

    Elias B. Hanna, Anita Y. Chen, Matthew T. Roe, Stephen D. Wiviott, Caroline S. Fox, Jorge F. Saucedo. (2011) Characteristics and In-Hospital Outcomes of Patients With Non–ST-Segment Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 4:9, 1002-1008
    

50. 50

    Kelly V. Liang, Francis Pike, Christos Argyropoulos, Lisa Weissfeld, Jeffrey Teuteberg, Mary Amanda Dew, Mark L. Unruh. (2011) Heart Failure Severity Scoring System and Medical- and Health-Related Quality-of-Life Outcomes: The HEMO Study. American Journal of Kidney Diseases 58:1, 84-92
    

51. 51

    Mark J. Sarnak, Robert N. Foley. (2011) Cardiovascular Mortality in the General Population Versus Dialysis: A Glass Half Full or Empty?. American Journal of Kidney Diseases 58:1, 4-6
    

52. 52

    Angela Yee-Moon WANG. (2011) Cardiovascular risk in diabetic end-stage renal disease patients. Journal of Diabetes 3:2, 119-131
    

53. 53

    Shigeo Horinaka. (2011) Use of Nicorandil in Cardiovascular Disease and Its Optimization. Drugs 71:9, 1105-1119
    

54. 54

    Osama El-Minshawy, Emad G. Kamel. (2011) Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study. International Urology and Nephrology 43:2, 507-512
    

55. 55

    Jelena Vekic, Aleksandra Zeljkovic, Natasa Bogavac-Stanojevic, Zorana Jelic-Ivanovic, Vesna Spasojevic-Kalimanovska, Sanja Simic-Ogrizovic, Violeta Dopsaj, Slavica Spasic. (2011) Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles. Clinical Biochemistry 44:8-9, 635-641
    

56. 56

    Yener Koc, Abdulkadir Unsal, Elbis Ahbap, Tamer Sakacı, Murvet Yilmaz. (2011) CLINICAL OUTCOME OF DIABETIC PERITONEAL DIALYSIS PATIENTS AND EVALUATION OF FACTORS AFFECTING MORTALITY: A SINGLE CENTRE’S EXPERIENCE FROM TURKEY. Journal of Renal Care 37:2, 94-100
    

57. 57

    Alejandro Recio-Mayoral, Debasish Banerjee, Chris Streather, Juan Carlos Kaski. (2011) Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease – a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216:2, 446-451
    

58. 58

    H. Noh, M. R. Yu, H. J. Kim, J. S. Jeon, S. H. Kwon, S. Y. Jin, J. Lee, J. Jang, J. O. Park, F. Ziyadeh, D. C. Han, H. B. Lee. (2011) Uremia induces functional incompetence of bone marrow-derived stromal cells. Nephrology Dialysis Transplantation
    

59. 59

    Karolina Szummer, Pia Lundman, Stefan H Jacobson, Staffan Schön, Johan Lindbäck, Ulf Stenestrand, Lars Wallentin, Tomas Jernberg. (2011) Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney International 79:9, 997-1004
    

60. 60

    Charles A. Herzog. (2011) Is There Something Special About Coronary Artery Disease in Dialysis Patients?. Seminars in Dialysis 24:3, 280-282
    

61. 61

    Y. Otsuka, S. Ishiwata, T. Inada, H. Kanno, E. Kyo, Y. Hayashi, H. Fujita, I. Michishita. (2011) Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry. European Heart Journal 32:7, 829-837
    

62. 62

    Yu-Feng Lin, Chiang-Ting Chien, Wei-Chih Kan, Yung-Ming Chen, Tzong-Shinn Chu, Kuan-Yu Hung, Tun-Jun Tsai, Kwan-Dun Wu, Ming-Shiou Wu. (2011) Pleiotropic Effects of Sevelamer Beyond Phosphate Binding in End-Stage Renal Disease Patients. Clinical Drug Investigation 31:4, 257-267
    

63. 63

    MOO YONG PARK, SOO JEONG CHOI, JIN KUK KIM, SEUNG DUK HWANG, JON SUH, HYE SUN SEO, DONG HUN KIM. (2011) Use of multidetector computed tomography for evaluating coronary artery disease in patients undergoing dialysis. Nephrology 16:3, 285-289
    

64. 64

    Nicole Schupp, Przemyslaw Rutkowski, Katarina Šebeková, André Klassen, Udo Bahner, Clemens Grupp, August Heidland, Helga Stopper. (2011) AT1 Receptor Antagonist Candesartan Attenuates Genomic Damage in Peripheral Blood Lymphocytes of Patients on Maintenance Hemodialysis Treatment. Kidney and Blood Pressure Research 34:3, 167-172
    

65. 65

    Robert C. Welsh, Sandra M. Cockfield, Patrica Campbell, Marilou Hervas-Malo, Gabor Gyenes, Vladamir Dzavik. (2011) Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation. Transplantation 91:2, 213-218
    

66. 66

    Dinna N. Cruz, Sean M. Bagshaw. (2011) Heart-Kidney Interaction: Epidemiology of Cardiorenal Syndromes. International Journal of Nephrology 2011, 1-11
    

67. 67

    Thomas Kümler, Gunnar H Gislason, Lars Kober, Finn Gustafsson, Morten Schou, Christian Torp-Pedersen. (2011) Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 years. BMC Cardiovascular Disorders 11:1, 37
    

68. 68

    Jihyun Son, Seung-Ho Hur, In Cheol Kim, Yun-Kyeong Cho, Hyoung-Seob Park, Hyuck-Jun Yoon, Hyungseop Kim, Chang-Wook Nam, Yoon-Nyun Kim, Kwon-Bae Kim. (2011) The Impact of Moderate to Severe Renal Insufficiency on Patients With Acute Myocardial Infarction. Korean Circulation Journal 41:6, 308
    

69. 69

    Nisha Bansal, Chi-yuan Hsu, Malini Chandra, Carlos Iribarren, Stephen P Fortmann, Mark A Hlatky, Alan S Go. (2011) Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: A cohort study. BMC Nephrology 12:1, 44
    

70. 70

    (2011) Nihon Toseki Igakkai Zasshi 44:5, 375-382
    

71. 71

    Chang Seong Kim, Joon Seok Choi, Jeong Woo Park, Eun Hui Bae, Seong Kwon Ma, Myung Ho Jeong, Young Jo Kim, Myeong Chan Cho, Chong Jin Kim, Soo Wan Kim, . (2011) Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction. Cardiovascular Diabetology 10:1, 95
    

72. 72

    G. Ocak, C. Y. Vossen, J. I. Rotmans, W. M. Lijfering, F. R. Rosendaal, K. J. Parlevliet, R. T. Krediet, E. W. Boeschoten, F. W. Dekker, M. Verduijn. (2011) Venous and arterial thrombosis in dialysis patients. Thrombosis and Haemostasis 106:6,
    

73. 73

    Hans-Henrik Parving, Michael Mauer, Paola Fioretto, Peter Rossing, Eberhard Ritz. Diabetic Nephropathy. In: Brenner and Rector's The Kidney. Elsevier, 2011:1411-1454.
    

74. 74

    B. N. Shah, K. Greaves. (2011) The Cardiorenal Syndrome: A Review. International Journal of Nephrology 2011, 1-11
    

75. 75

    Samuel M. Butman. (2010) It's not the dye, but the “die” in dialysis: Which coronary revascularization strategy really is best?. Catheterization and Cardiovascular Interventions 76:7, 949-950
    

76. 76

    Ahmed Abdel-Latif, Debabrata Mukherjee, Paymon Mesgarzadeh, Khaled M. Ziada. (2010) Drug-eluting stents in patients with end-stage renal disease: Meta-analysis and systematic review of the literature. Catheterization and Cardiovascular Interventions 76:7, 942-948
    

77. 77

    Lisa M. Miller, Manish M. Sood, Amy R. Sood, Martina Reslerova, Paul Komenda, Claudio Rigatto, Joe Bueti. (2010) Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. International Urology and Nephrology 42:4, 1007-1014
    

78. 78

    S. B. Sandoval, E. Stoyanova, E. Coll, S. Pastor, J. Reyes, E. Andres, J. Ballarin, N. Xamena, R. Marcos. (2010) Genetic damage in chronic renal failure patients is associated with the glomerular filtration rate index. Mutagenesis 25:6, 603-608
    

79. 79

    Antonis S. Manolis, Spyridon Koulouris, Kostas Triantafyllou, Dimitris Sakellariou, Sokratis Pastromas, Helen Melita. Anemia and Cardiovascular Disease. In: Alternatives to Blood Transfusion in Transfusion Medicine. Wiley-Blackwell, 2010:229-251.
    

80. 80

    ERIC CHONG, KIAN K. POH, SHEN LIANG, CHAO Y. SOON, HUAY-CHEEM TAN. (2010) Comparison of Risks and Clinical Predictors of Contrast-Induced Nephropathy in Patients Undergoing Emergency versus Nonemergency Percutaneous Coronary Interventions. Journal of Interventional Cardiology 23:5, 451-459
    

81. 81

    Mirjana Đerić, Velibor S. Čabarkapa. (2010) Cardiovascular Biomarkers in Chronic Kidney Disease. Journal of Medical Biochemistry 29:4, 298-303
    

82. 82

    Hussein H. Karnib, Fuad N. Ziyadeh. (2010) The cardiorenal syndrome in diabetes mellitus. Diabetes Research and Clinical Practice 89:3, 201-208
    

83. 83

    S. Hiremath, S. P. Doucette, R. Richardson, K. Chan, K. Burns, D. Zimmerman. (2010) Left ventricular growth after 1 year of haemodialysis does not correlate with arteriovenous access flow: a prospective cohort study. Nephrology Dialysis Transplantation 25:8, 2656-2661
    

84. 84

    Giuseppe Bruschi, Tiziano Colombo, Luca Botta, Paola Colombo, Stefano Pelenghi, Salvatore Trunfio, Aldo Cannata, Bruno Merlanti, Roberto Paino, Silvio Klugmann, Luigi Martinelli. (2010) Off-pump coronary revascularization in chronic dialysis-dependent patients: early outcomes at a single institution. Journal of Cardiovascular Medicine 11:7, 481-485
    

85. 85

    Qiang Fu, Shuichi Ishikawa, Naoyuki Yokoyama, Ken Kozuma, Kaoru Takada, Aki Muraki, Takaaki Isshiki. (2010) Enhanced platelet activation following coronary stent implantation in patients on hemodialysis. Cardiovascular Intervention and Therapeutics 25:2, 72-77
    

86. 86

    Hari Krishan Aggarwal, Deepak Jain, Mohit Lathar, R.K. Yadav, Amrish Sawhney. (2010) Lipoprotein-A and carotid intima media thickness as cardiovascular risk factors in patients of chronic kidney disease. Renal Failure 32:6, 647-652
    

87. 87

    Ching Yan Goh, Claudio Ronco. (2010) CARDIO-RENAL SYNDROMES. Journal of Renal Care 36, 9-17
    

88. 88

    S. M. Bagshaw, D. N. Cruz, N. Aspromonte, L. Daliento, F. Ronco, G. Sheinfeld, S. D. Anker, I. Anand, R. Bellomo, T. Berl, I. Bobek, A. Davenport, M. Haapio, H. Hillege, A. House, N. Katz, A. Maisel, S. Mankad, P. McCullough, A. Mebazaa, A. Palazzuoli, P. Ponikowski, A. Shaw, S. Soni, G. Vescovo, N. Zamperetti, P. Zanco, C. Ronco, . (2010) Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation 25:5, 1406-1416
    

89. 89

    E. Stoyanova, S. B. Sandoval, L. A. Zuniga, N. El-Yamani, E. Coll, S. Pastor, J. Reyes, E. Andres, J. Ballarin, N. Xamena, R. Marcos. (2010) Oxidative DNA damage in chronic renal failure patients. Nephrology Dialysis Transplantation 25:3, 879-885
    

90. 90

    Tejas Patel, David M. Charytan. (2010) Cardiovascular Complications in Diabetic Kidney Disease. Seminars in Dialysis 23:2, 169-177
    

91. 91

    Markus P. Schlaich, Henry Krum, Paul A. Sobotka. (2010) Renal Sympathetic Nerve Ablation: The New Frontier in the Treatment of Hypertension. Current Hypertension Reports 12:1, 39-46
    

92. 92

    Kazuaki Negishi, Mitsuru Kobayashi, Izuru Ochiai, Yuji Yamazaki, Hisashi Hasegawa, Takeyoshi Yamashita, Takehisa Shimizu, Shu Kasama, Masahiko Kurabayashi. (2010) Association Between Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Maintenance Hemodialysis Patients. Circulation Journal 74:12, 2734-2740
    

93. 93

    Daniel E. Weiner, Mark J. Sarnak. Cardiovascular Disease in Patients with Chronic Kidney Disease. In: Chronic Kidney Disease, Dialysis, and Transplantation. Elsevier, 2010:128-144.
    

94. 94

    C. Ronco, P. McCullough, S. D. Anker, I. Anand, N. Aspromonte, S. M. Bagshaw, R. Bellomo, T. Berl, I. Bobek, D. N. Cruz, L. Daliento, A. Davenport, M. Haapio, H. Hillege, A. A. House, N. Katz, A. Maisel, S. Mankad, P. Zanco, A. Mebazaa, A. Palazzuoli, F. Ronco, A. Shaw, G. Sheinfeld, S. Soni, G. Vescovo, N. Zamperetti, P. Ponikowski, . (2009) Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. European Heart Journal
    

95. 95

    D. Habedank, T. Kung, T. Karhausen, S. von Haehling, W. Doehner, J. C. Schefold, D. Hasper, S. Reinke, S. D. Anker, P. Reinke. (2009) Exercise capacity and body composition in living-donor renal transplant recipients over time. Nephrology Dialysis Transplantation 24:12, 3854-3860
    

96. 96

    Melchior Seyfarth, Adnan Kastrati, Johannes F.E. Mann, Gjin Ndrepepa, Robert A. Byrne, Stefanie Schulz, Julinda Mehilli, Albert Schömig. (2009) Prognostic Value of Kidney Function in Patients With ST-Elevation and Non–ST-Elevation Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention. American Journal of Kidney Diseases 54:5, 830-839
    

97. 97

    M. Khaled Shamseddin, Patrick S. Parfrey. (2009) Mechanisms of the cardiorenal syndromes. Nature Reviews Nephrology 5:11, 641-649
    

98. 98

    Stefano Savonitto, Carlo Briguori, Flavio Ribichini, Fabrizio Tomai, Emanuela Piccaluga. (2009) Primary percutaneous coronary intervention: different outcome for different subgroups?. Journal of Cardiovascular Medicine 10:Suppl 1, S27-S34
    

99. 99

    Ralf Dikow, Caroline Wasserhess, Katrin Zimmerer, Lars Philipp Kihm, Matthias Schaier, Vedat Schwenger, Stefan Hardt, Christiane Tiefenbacher, Hugo Katus, Martin Zeier, Lisa Marie Gross. (2009) Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats. Basic Research in Cardiology 104:5, 571-579
    

100. 100

     Khaled M. Ziada, Ahmed Abdel-Latif. (2009) Drug-Eluting Stents in Patients With ESRD on Dialysis: A Small Step Forward. American Journal of Kidney Diseases 54:2, 197-200
     

101. 101

     Susumu Manabe, Tomoki Shimokawa, Toshihiro Fukui, Ken-u Fumimoto, Naomi Ozawa, Hiroshi Seki, Shuichiro Takanashi. (2009) Coronary Artery Bypass Surgery Versus Percutaneous Coronary Artery Intervention in Patients on Chronic Hemodialysis: Does a Drug-Eluting Stent Have an Impact on Clinical Outcome?. Journal of Cardiac Surgery 24:3, 234-239
     

102. 102

     Wilbert S. Aronow. (2009) Acute and Chronic Management of Atrial Fibrillation in Patients With Late-Stage CKD. American Journal of Kidney Diseases 53:4, 701-710
     

103. 103

     Sikander P Surana, Leonardo V Riella, Sai Ram Keithi-Reddy, David M Charytan, Ajay K Singh. (2009) Acute coronary syndrome in ESRD patients. Kidney International 75:5, 558-562
     

104. 104

     Alan K. Berger, Charles A. Herzog. (2009) Connecting the C's: Coronaries, Creatinine, Compliance, CRUSADE. American Journal of Kidney Diseases 53:3, 366-369
     

105. 105

     Debabrata Mukherjee. (2009) Spatial distribution of coronary artery thromboses in patients with chronic kidney disease: implications for diagnosis and treatment. Kidney International 75:1, 7-9
     

106. 106

     Peter B. Berger, Patricia J.M. Best. (2009) Does Kidney Function Alter the Benefit of Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction?. JACC: Cardiovascular Interventions 2:1, 34-36
     

107. 107

     Keisuke Kitaura, Masahiro Kida, Keizou Harima. (2009) Assessment of Peripheral Arterial Disease of Lower Limbs with Ultrasonography and Ankle Brachial Index at the Initiation of Hemodialysis. Renal Failure 31:9, 785-790
     

108. 108

     ILAN GOLDENBERG, ARTHUR J. MOSS. (2008) Implantable Cardioverter Defibrillator Efficacy and Chronic Kidney Disease: Competing Risks of Arrhythmic and Nonarrhythmic Mortality. Journal of Cardiovascular Electrophysiology 19:12, 1281-1283
     

109. 109

     A. Jaroszynski, E. Czekajska-Chechab, A. Drelich-Zbroja, T. Zapolski, A. Ksiazek. (2008) Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T. Nephrology Dialysis Transplantation 24:3, 1003-1008
     

110. 110

     Steven M. Brunelli, Ravi I. Thadhani, Katherine E. Lynch, Elizabeth D. Ankers, Marshall M. Joffe, Raymond Boston, Yuchaio Chang, Harold I. Feldman. (2008) Association Between Long-term Blood Pressure Variability and Mortality Among Incident Hemodialysis Patients. American Journal of Kidney Diseases 52:4, 716-726
     

111. 111

     Jeffrey B. Washam, George L. Adams. (2008) Risks and Benefits of Antiplatelet Therapy in Uremic Patients. Advances in Chronic Kidney Disease 15:4, 370-377
     

112. 112

     Steven Fishbane. (2008) Anemia and Cardiovascular Risk in the Patient with Kidney Disease. Heart Failure Clinics 4:4, 401-410
     

113. 113

     G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, K. Stamatellopoulos, A. Laggouranis, K. N. Vemmos. (2008) Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrology Dialysis Transplantation 24:1, 194-200
     

114. 114

     H. Trivedi, Q. Xiang, J. P. Klein. (2008) Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrology Dialysis Transplantation 24:1, 258-266
     

115. 115

     Jain Bhaskara Pillai, Rakesh M. Suri. (2008) Coronary Artery Surgery and Extracorporeal Circulation: The Search for a New Standard. Journal of Cardiothoracic and Vascular Anesthesia 22:4, 594-610
     

116. 116

     Jennifer R. Brown, Patricia A. Uber, Mandeep R. Mehra. (2008) The progressive cardiorenal syndrome in heart failure: Mechanisms and therapeutic insights. Current Treatment Options in Cardiovascular Medicine 10:4, 342-348
     

117. 117

     Harvey D White, Derek P Chew. (2008) Acute myocardial infarction. The Lancet 372:9638, 570-584
     

118. 118

     Katharina Hohenstein, Bruno Watschinger. (2008) Hypertonie und Niere. Wiener Medizinische Wochenschrift 158:13-14, 359-364
     

119. 119

     Howard A. Cooper, Cecilia Monge, Julio A. Panza. (2008) Patients with end-stage renal disease and acute myocardial infarction have poor short-term outcomes despite modern cardiac intensive care. Coronary Artery Disease 19:4, 231-235
     

120. 120

     D. Martí, C. Escobar, N. Dedieu, F. Liaño, M. Jiménez Mena, E. Asín. (2008) Deterioro agudo de la función renal en una Unidad Coronaria en España. Medicina Intensiva 32:4, 163-167
     

121. 121

     T. Hayashi, Y. Obi, T. Kimura, K.-i. Iio, S. Sumitsuji, Y. Takeda, Y. Nagai, E. Imai. (2008) Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy. Nephrology Dialysis Transplantation 23:9, 2936-2942
     

122. 122

     Jun Wang, Ah Siew Sim, Xing Li Wang, Chris Salonikas, Mary Moriatis, Daya Naidoo, David E.L. Wilcken. (2008) Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease. Atherosclerosis 197:2, 853-859
     

123. 123

     Simonetta Genovesi, Antonio Vincenti, Emanuela Rossi, Daniela Pogliani, Irene Acquistapace, Andrea Stella, Maria Grazia Valsecchi. (2008) Atrial Fibrillation and Morbidity and Mortality in a Cohort of Long-term Hemodialysis Patients. American Journal of Kidney Diseases 51:2, 255-262
     

124. 124

     Ilan Goldenberg, Anant K. Vyas, W. Jackson Hall, Arthur J. Moss, Hongyue Wang, Hua He, Wojciech Zareba, Scott McNitt, Mark L. Andrews. (2008) Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. Journal of the American College of Cardiology 51:3, 288-296
     

125. 125

     Arif Mutwali, Liam G Glynn, Donal Reddan. (2008) Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease. American Journal of Cardiovascular Drugs 8:4, 219-231
     

126. 126

     Sang-Hee Lee, Young-Jo Kim, Woong Kim, Jong-Seon Park, Dong-Gu Shin, Seung-Ho Hur, Chong-Jin Kim, Myeong-Chan Cho, Shung-Chull Chae, Myung-Ho Jeong, Taek-Jong Hong, Doo-Il Kim, Kee-Sik Kim, Korean Acute Myocardial Infarction. (2008) Clinical Outcomes and Therapeutic Strategy in Patients With Acute Myocardial Infarction According to Renal Function. Circulation Journal 72:9, 1410-1418
     

127. 127

     Toru Aoyama, Hideki Ishii, Takanobu Toriyama, Hiroshi Takahashi, Hirotake Kasuga, Ryuichiro Murakami, Tetsuya Amano, Tadayuki Uetani, Yoshinari Yasuda, Yukio Yuzawa, Shoichi Maruyama, Seiichi Matsuo, Tatsuaki Matsubara, Toyoaki Murohara. (2008) Sirolimus-Eluting Stents vs Bare Metal Stents for Coronary Intervention in Japanese Patients With Renal Failure on Hemodialysis. Circulation Journal 72:1, 56-60
     

128. 128

     Ioannis Katerinis, Quan-Vinh Nguyen, Jean-Luc Magnin, Eric Descombes. (2008) Cardiac Findings in Asymptomatic Chronic Hemodialysis Patients with Persistently Elevated Cardiac Troponin I Levels. Renal Failure 30:4, 357-362
     

129. 129

     Eberhard Ritz, Christoph Wanner. Cardiovascular Complications of End-Stage Renal Disease. In: Therapy in Nephrology & Hypertension. Elsevier, 2008:773-782.
     

130. 130

     Isidoro González Maqueda, Carlos Casanova Rodríguez, Carlos Escobar Cervantes, Angel Garcia Garcia, Juan R. Peraira Moral, Elsa Prieto Moriche, Cristina Tejero Romero. (2008) Enfermedad cardiovascular y función renal. Mecanismos patogénicos. Revista Española de Cardiología Suplementos 8:5, 10E-21E
     

131. 131

     Coen van Guldener, Prabath W.B. Nanayakkara, Coen D.A. Stehouwer. (2007) Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. Clinical Chemistry and Laboratory Medicine 45:12, 1683-1687
     

132. 132

     Vlad C Vasile, Allan S Jaffe. (2007) New potential uses for cardiac troponins. Biomarkers in Medicine 1:4, 491-501
     

133. 133

     Sujethra Vasu, Luis Gruberg, David L. Brown. (2007) The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction. Catheterization and Cardiovascular Interventions 70:5, 701-705
     

134. 134

     J. D. Schold, T. R. Srinivas, L. K. Kayler, H. U. Meier-Kriesche. (2007) The Overlapping Risk Profile Between Dialysis Patients Listed and Not Listed for Renal Transplantation. American Journal of Transplantation 0:0, 071105081616013-???
     

135. 135

     Jean L. Holley. (2007) Palliative Care in End-Stage Renal Disease: Illness Trajectories, Communication, and Hospice Use. Advances in Chronic Kidney Disease 14:4, 402-408
     

136. 136

     Khaled M. Ziada. (2007) Coronary revascularization in end-stage renal disease. Current Cardiology Reports 9:5, 389-395
     

137. 137

     B. Weidtmann, H. Schunkert. (2007) Niereninsuffizienz und kardiovaskuläre Erkrankungen. Der Internist 48:8, 770-778
     

138. 138

     Nelson Kopyt. Chronic Kidney Disease. In: Comprehensive Management of High Risk Cardiovascular Patients. CRC Press, 2007:463-500.
     

139. 139

     Davinder S. Jassal, Tomas G. Neilan, Michael H. Picard, Malissa J. Wood. (2007) Stress Echocardiography: Abnormal Response of Tissue Doppler?Derived Indices to Dobutamine in the Absence of Obstructive Coronary Artery Disease in Patients with Chronic Renal Failure. Echocardiography 24:6, 580-586
     

140. 140

     Ranjit John, Katherine Lietz, Stephen Huddleston, Arthur Matas, Kenneth Liao, Sara Shumway, Lyle Joyce, R. Morton Bolman. (2007) Perioperative outcomes of cardiac surgery in kidney and kidney–pancreas transplant recipients. The Journal of Thoracic and Cardiovascular Surgery 133:5, 1212-1219
     

141. 141

     Matthew Forrester, William Cohn. Coronary Artery Bypass Grafting in Dialysis-Dependent Renal Failure Patients. In: Cardiac Surgery in Chronic Renal Failure. Blackwell Publishing Ltd, 2007:63-74.
     

142. 142

     Charles A. Herzog, Khalid Ashai. Percutaneous Coronary Revascularization in Patients with End-Stage Renal Disease. In: Cardiac Surgery in Chronic Renal Failure. Blackwell Publishing Ltd, 2007:19-50.
     

143. 143

     Ejikeme O. Obasi, Rakhi Khanna, Vidya Naidu, Kelly E. Guglielmi, Demetrios Zikos. Dialysis and the Chronic Renal Failure Patient. In: Cardiac Surgery in Chronic Renal Failure. Blackwell Publishing Ltd, 2007:1-18.
     

144. 144

     David Charytan, Richard E. Kuntz, Laura Mauri, Christopher DeFilippi. (2007) Distribution of Coronary Artery Disease and Relation to Mortality in Asymptomatic Hemodialysis Patients. American Journal of Kidney Diseases 49:3, 409-416
     

145. 145

     John L. Brusch. Infective Endocarditis of Immunocompromised Patients. Informa Healthcare, 2007:231-240.
     

146. 146

     Sébastien Bergeron, Graham S. Hillis, Eric N. Haugen, Jae K. Oh, Kent R. Bailey, Patricia A. Pellikka. (2007) Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. American Heart Journal 153:3, 385-391
     

147. 147

     Abid R. Assali, David Brosh, Itsik Ben-Dor, Alejandro Solodky, Shmuel Fuchs, Igal Teplitsky, Ran Kornowski. (2007) The impact of renal insufficiency on patients outcomes in emergent angioplasty for acute myocardial infarction. Catheterization and Cardiovascular Interventions 69:3, 395-400
     

148. 148

     Murat Sezer, Mustafa Ozcan, Irem Okcular, Ali Elitok, Sabahattin Umman, Berrin Umman, Yelda Tayyareci, Ayhan Olcay, Yilmaz Nisanci, Ahmet Kaya Bilge, Mehmet Meric. (2007) A potential evidence to explain the reason behind the devastating prognosis of coronary artery disease in uraemic patients: Renal insufficiency is associated with poor coronary collateral vessel development. International Journal of Cardiology 115:3, 366-372
     

149. 149

     David W. JOHNSON, Ann-Maree CRAVEN, Nicole Maree ISBEL. (2007) Modification of cardiovascular risk in hemodialysis patients: An evidence-based review. Hemodialysis International 11:1,
     

150. 150

     Mats Johansson, Sinsia A Gao, Peter Friberg, Marita Annerstedt, Jan Carlström, Ted Ivarsson, Gert Jensen, Susanne Ljungman, Öivind Mathillas, Finn-David Nielsen, Ulf Strömbom. (2007) Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. Journal of Hypertension 25:1, 163-168
     

151. 151

     Hideki Ishii, Takanobu Toriyama, Toru Aoyama, Hiroshi Takahashi, Shigeki Yamada, Hirotake Kasuga, Satoshi Ichimiya, Masaaki Kanashiro, Hirotsugu Mitsuhashi, Shoichi Maruyama, Seiichi Matsuo, Keiko Naruse, Tatsuaki Matsubara, Toyoaki Murohara. (2007) Efficacy of oral nicorandil in patients with end-stage renal disease: A retrospective chart review after coronary angioplasty in japanese patients receiving hemodialysis. Clinical Therapeutics 29:1, 110-122
     

152. 152

     Takayasu Ohtake. (2007) Nihon Toseki Igakkai Zasshi 40:2, 132-134
     

153. 153

     Junichi Yamaguchi, Hiroshi Kasanuki, Yasuhiro Ishii, Masahiro Yagi, Michitaka Nagashima, Shinya Fujii, Ryo Koyanagi, Hiroshi Ogawa, Nobuhisa Hagiwara, Kazuo Haze, Tetsuya Sumiyoshi, Takashi Honda, The Heart Institute of Japan, Cardi. (2007) Serum Creatinine on Admission Predicts Long-Term Mortality in Acute Myocardial Infarction Patients Undergoing Successful Primary Angioplasty. Circulation Journal 71:9, 1354-1359
     

154. 154

     Georg Biesenbach, Johann Loipl, Bernhard Schmekal, Otmar Janko. (2007) Different Risk Factors and Causes for Early Death after Initiating Dialysis in Diabetic and Non-Diabetic Patients. Renal Failure 29:1, 49-53
     

155. 155

     , G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:2, 103-117
     

156. 156

     PHILIP T ONDOCIN, SRIRAM S NARSIPUR. (2006) Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis. Nephrology 11:6, 497-501
     

157. 157

     Nelson Kopyt. Chronic Kidney Disease. Informa Healthcare, 2006:463-500.
     

158. 158

     B. J. Witczak, A. Hartmann, T. Jenssen, A. Foss, K. Endresen. (2006) Routine Coronary Angiography in Diabetic Nephropathy Patients Before Transplantation. American Journal of Transplantation 6:10, 2403-2408
     

159. 159

     Robert Robitaille, Jean-Philippe Lafrance, Martine Leblanc. (2006) Reviews: Altered Laboratory Findings Associated with End-Stage Renal Disease. Seminars in Dialysis 19:5, 373-380
     

160. 160

     , G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:1, 8-30
     

161. 161

     Mehmet Horoz, Filiz F. Bolukbas, Cengiz Bolukbas, Mehmet Aslan, Ahmet O. Koylu, Necla Gunaydin, Sahbettin Selek, Abdurrahim Kocyigit. (2006) The association of circulating leptin level with peripheral DNA damage in hemodialysis subjects. Clinical Biochemistry 39:9, 918-922
     

162. 162

     H Hase, T Tsunoda, Y Tanaka, Y Takahashi, Y Imamura, H Ishikawa, Y Inishi, N Joki. (2006) Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney International 70:6, 1142-1148
     

163. 163

     David Charytan, Laura Mauri, Anupam Agarwal, Steven Servoss, Benjamin Scirica, Richard E. Kuntz,. (2006) The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. American Heart Journal 152:3, 558-564
     

164. 164

     Hiroki Hase, Nobuhiko Joki, Hiroyasu Ishikawa, Tomokatsu Saijyo, Yuri Tanaka, Yasunori Takahashi, Yoji Inishi, Yoshihiko Imamura, Masato Nakamura, Masao Moroi. (2006) Independent Risk Factors for Progression of Coronary Atherosclerosis in Hemodialysis Patients. Therapeutic Apheresis and Dialysis 10:4, 321-327
     

165. 165

     Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, Mark L. Andrews, W. Jackson Hall, Henry Greenberg, Robert B. Case. (2006) Relations Among Renal Function, Risk of Sudden Cardiac Death, and Benefit of the Implanted Cardiac Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. The American Journal of Cardiology 98:4, 485-490
     

166. 166

     Carmelo J. Panetta, Charles A. Herzog, Timothy D. Henry. (2006) Acute coronary syndromes in patients with renal disease: What are the issues?. Current Cardiology Reports 8:4, 296-300
     

167. 167

     Allan S. Jaffe, Harlan M. Krumholz, Diane J. Catellier, Kenneth E. Freedland, Vera Bittner, James A. Blumenthal, James E. Calvin, James Norman, Rafael Sequeira, Christopher O'Connor, Michael W. Rich, David Sheps, Colin Wu. (2006) Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. American Heart Journal 152:1, 126-135
     

168. 168

     S. Michael Gharacholou, Karen P. Alexander. (2006) Issues with care in the elderly patient presenting with acute ischemia. Current Heart Failure Reports 3:2, 51-56
     

169. 169

     J Jacobi, M Porst, N Cordasic, B Namer, R E Schmieder, K-U Eckardt, K F Hilgers. (2006) Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats. Kidney International 69:11, 2013-2021
     

170. 170

     Naoko Fujimoto, Kunitoshi Iseki, Kiyoyuki Tokuyama, Masahiro Tamashiro, Shuichi Takishita. (2006) Significance of coronary artery calcification score (CACS) for the detection of coronary artery disease (CAD) in chronic dialysis patients. Clinica Chimica Acta 367:1-2, 98-102
     

171. 171

     Angela Yee-Moon Wang, Daniel Tak-Mao Chan, Kar-Neng Lai. (2006) Cardiovascular Disease in End-stage Renal Disease. Hong Kong Journal of Nephrology 8:1, 10-16
     

172. 172

     G Pernod, J-L Bosson, D Golshayan, C Barro, G Forneris, G Martina, G Bonfant, J-M Hurot, C Turc-Baron, C Jouet, J Theytaz, A Jeantet, J-P Wauters, D Cordonnier. (2006) Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort. Kidney International
     

173. 173

     François Schiele, Pierre Legalery, Katy Didier, Nicolas Meneveau, Marie France Seronde, Fiona Caulfield, Didier Ducloux, Patrick Bechetoille, Dominique Magnin, Rene Faivre, Jean-Pierre Bassand. (2006) Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. American Heart Journal 151:3, 661-667
     

174. 174

     Jin H. Han, Abhinav Chandra, Jyotsna Mulgund, Matthew T. Roe, Eric D. Peterson, Lynda A. Szczech, Uptal Patel, E. Magnus Ohman, Christopher J. Lindsell, W. Brian Gibler. (2006) Chronic Kidney Disease in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes. The American Journal of Medicine 119:3, 248-254
     

175. 175

     Wolfgang C. Winkelmayer, David M. Charytan, Raisa Levin, Jerry Avorn. (2006) Poor Short-Term Survival and Low Use of Cardiovascular Medications in Elderly Dialysis Patients After Acute Myocardial Infarction. American Journal of Kidney Diseases 47:2, 301-308
     

176. 176

     Andrew T. Yan, Raymond T. Yan, Mary Tan, Christian Constance, Claude Lauzon, Jeffrey Zaltzman, Ron Wald, David Fitchett, Anatoly Langer, Shaun G. Goodman. (2006) Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Canadian Journal of Cardiology 22:2, 115-120
     

177. 177

     Todd M. Dewey, Morley A. Herbert, Syma L. Prince, Carrie L. Robbins, Christina M. Worley, Mitchell J. Magee, Michael J. Mack. (2006) Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease?. The Annals of Thoracic Surgery 81:2, 591-598
     

178. 178

     Manisha Das, Wilbert S. Aronow, John A. McClung, Robert N. Belkin. (2006) Increased Prevalence of Coronary Artery Disease, Silent Myocardial Ischemia, Complex Ventricular Arrhythmias, Atrial Fibrillation, Left Ventricular Hypertrophy, Mitral Annular Calcium, and Aortic Valve Calcium in Patients With Chronic Renal Insufficiency. Cardiology in Review 14:1, 14-17
     

179. 179

     Susumu Manabe, Hirokuni Arai, Hiroyuki Tanaka, Noriyuki Tabuchi, Makoto Sunamori. (2006) Physiological comparison of off-pump and on-pump coronary artery bypass grafting in patients on chronic hemodialysis. The Japanese Journal of Thoracic and Cardiovascular Surgery 54:1, 3-10
     

180. 180

     K. Kobras, N. Schupp, K. Nehrlich, M. Adelhardt, U. Bahner, J. Vienken, A. Heidland, K. Sebekova, H. Stopper. (2006) Relation between Different Treatment Modalities and Genomic Damage of End-Stage Renal Failure Patients. Kidney and Blood Pressure Research 29:1, 10-17
     

181. 181

     Yoshihisa Hirakawa, Yuichiro Masuda, Masafumi Kuzuya, Akihisa Iguchi, Takaya Kimata, Kazumasa Uemura. (2006) Association of Renal Insufficiency With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Interventions. International Heart Journal 47:5, 745-752
     

182. 182

     Charles A. Herzog. (2005) Sudden Cardiac Death and Acute Myocardial Infarction in Dialysis Patients: Perspectives of a Cardiologist. Seminars in Nephrology 25:6, 363-366
     

183. 183

     Herwig-Ulf Meier-Kriesche, Jesse D. Schold. (2005) The Impact of Pretransplant Dialysis on Outcomes in Renal Transplantation. Seminars in Dialysis 18:6, 499-504
     

184. 184

     Tammy M. Keough-Ryan, Bryce A. Kiberd, Christine S. Dipchand, Jafna L. Cox, Caren L. Rose, Kara J. Thompson, Catherine M. Clase. (2005) Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia. American Journal of Kidney Diseases 46:5, 845-855
     

185. 185

     Rajiv Gupta, Yochai Birnbaum, Barry Uretsky. Coronary risk and chronic kidney disease. In: Contrast-Induced Nephropathy in Interventional Cardiovascular Medicine. CRC Press, 2005:47-56.
     

186. 186

     Antonio Bartorelli, Giancarlo Marenzi. Effects of renal chronic kidney disease and contrast-induced nephropathy on prognosis and treatment outcomes of acute coronary syndromes. In: Contrast-Induced Nephropathy in Interventional Cardiovascular Medicine. CRC Press, 2005:57-75.
     

187. 187

     JOHN J V MCMURRAY. (2005) Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment. Kidney International 68:4, 1419-1426
     

188. 188

     Britt B. Newsome, David G. Warnock, Catarina I. Kiefe, Norman W. Weissman, Thomas K. Houston, Robert M. Centor, Sharina D. Person, William M. McClellan, Jeroan J. Allison. (2005) Delay in Time to Receipt of Thrombolytic Medication Among Medicare Patients With Kidney Disease. American Journal of Kidney Diseases 46:4, 595-602
     

189. 189

     M KONTOS, R GARG, F ANDERSON, J TATUM, J ORNATO, R JESSE. (2005) Outcomes in patients admitted for chest pain with renal failure and troponin I elevations. American Heart Journal 150:4, 674-680
     

190. 190

     Martin J. Holzmann, Staffan Ahnve, Niklas Hammar, Lena Jörgensen, Kristina Klerdal, Kenneth Pehrsson, Torbjörn Ivert. (2005) Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 130:3, 746.e1-746.e8
     

191. 191

     Anthony J. Bleyer, John Burkart, Michael Piazza, Gregory Russell, Michael Rohr, J. Jeffrey Carr. (2005) Changes in Cardiovascular Calcification After Parathyroidectomy in Patients With ESRD. American Journal of Kidney Diseases 46:3, 464-469
     

192. 192

     CHARLES A HERZOG, SHULING LI, ERIC D WEINHANDL, JEREMY W STRIEF, ALLAN J COLLINS, DAVID T GILBERTSON. (2005) Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney International 68:2, 818-825
     

193. 193

     B. Fellstrom, A. G. Jardine, I. Soveri, E. Cole, H.-H. Neumayer, B. Maes, C. Gimpelewicz, H. Holdaas, . (2005) Renal Dysfunction Is a Strong and Independent Risk Factor for Mortality and Cardiovascular Complications in Renal Transplantation. American Journal of Transplantation 5:8, 1986-1991
     

194. 194

     F. Schiele. (2005) L'insuffisance rénale chronique, facteur de risque indépendant de mortalité après un infarctus aigu. Annales de Cardiologie et d'Angéiologie 54:4, 161-167
     

195. 195

     E. Fragedaki. (2005) Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrology Dialysis Transplantation 20:9, 1936-1943
     

196. 196

     S. Michael Gharacholou, Karen P. Alexander. (2005) Issues with care in the elderly patient presenting with acute ischemia. Current Cardiology Reports 7:4, 270-275
     

197. 197

     Jolanta Malyszko, Jacek S Malyszko, Hanna Bachorzewska-Gajewska. (2005) Cardiovascular risk in chronic renal disease and transplantation prevention and management. Expert Opinion on Pharmacotherapy 6:6, 929-943
     

198. 198

     Peter A. McCullough. (2005) Evaluation and treatment of coronary artery disease in patients with end-stage renal disease. Kidney International 67:s95, s51-s58
     

199. 199

     Rory O'Hanlon, Donal N. Reddan. (2005) Treatment of Acute Coronary Syndromes in Patients Who Have Chronic Kidney Disease. Medical Clinics of North America 89:3, 563-585
     

200. 200

     Peter B. Berger, Patricia J.M. Best, Eric J. Topol, Jennifer White, Peter M. DiBattiste, Albert W. Chan, Steen D. Kristensen, Howard C. Herrmann, David J. Moliterno. (2005) The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: The Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial. American Heart Journal 149:5, 869-875
     

201. 201

     (2005) K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. American Journal of Kidney Diseases 45, 16-153
     

202. 202

     SATOKO NAKAMURA, CHINAMI OGATA, NAOHIKO AIHARA, OSAMU SASAKI, FUMIKI YOSHIHARA, HAJIME NAKAHAMA, TAKASHI INENAGA, GENJIRO KIMURA, YUHEI KAWANO. (2005) QTc dispersion in haemodialysis patients with cardiac complications. Nephrology 10:2, 113-118
     

203. 203

     R. Vanholder. (2005) Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrology Dialysis Transplantation 20:6, 1048-1056
     

204. 204

     Vikram Kalra, Sandeep Mahajan, Sanjay Kumar Agarwal, Suresh Chander Tiwari. (2005) Cardiorenal Disease: A Clinical Intersection. International Urology and Nephrology 37:1, 175-184
     

205. 205

     Raja Varma, Wilbert S. Aronow, John A. McClung, Renee Garrick, Paul F. Vistainer, Melvin B. Weiss, Robert N. Belkin. (2005) Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. The American Journal of Cardiology 95:6, 742-743
     

206. 206

     Ruud M.A. van de Wal, Ben L. van Brussel, Adriaan A. Voors, Tom D.J. Smilde, Johannes C. Kelder, Henry A. van Swieten, Wiek H. van Gilst, Dirk Jan van Veldhuisen, H.W. Thijs Plokker. (2005) Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. The Journal of Thoracic and Cardiovascular Surgery 129:2, 330-335
     

207. 207

     Wolfgang Bocksch, Suzanne Fateh-Moghadam, Eda Mueller, Sonja Huehns, Juergen Waigand, Rainer Dietz. (2005) Percutaneous Coronary Intervention in Patients with End-Stage Renal Disease. Kidney and Blood Pressure Research 28:5-6, 275-279
     

208. 208

     Paulo Benigno Pena Batista, Antônio Alberto Lopes, Fernando Antonio Costa. (2005) Association Between Attributed Cause of End-Stage Renal Disease and Risk of Death in Brazilian Patients Receiving Renal Replacement Therapy. Renal Failure 27:6, 651-656
     

209. 209

     K. Kundhal, C.E. Lok. (2005) Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease. Nephron Clinical Practice 101:2, c47-c52
     

210. 210

     Christian Mueller, Kirsten Laule-Kilian, Andre Scholer, Charly Nusbaumer, Thomas Zeller, Daniel Staub, Andre P. Perruchoud. (2005) B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison. Kidney International 67:1, 278-284
     

211. 211

     Hannelore Hampl, Lars Hennig, Christian Rosenberger, Lutz Gogoll, Eberhard Riedel, Armin Scherhag. (2005) Optimized Heart Failure Therapy and Complete Anemia Correction on Left-Ventricular Hypertrophy in Nondiabetic and Diabetic Patients Undergoing Hemodialysis. Kidney and Blood Pressure Research 28:5-6, 353-362
     

212. 212

     Richard J. Harp, S. William Stavropoulos, Alan G. Wasserstein, Timothy W.I. Clark. (2005) Pulmonary Hypertension Among End-Stage Renal Failure Patients Following Hemodialysis Access Thrombectomy. CardioVascular and Interventional Radiology 28:1, 17-22
     

213. 213

     Hannelore Hampl, Lars Hennig, Christian Rosenberger, Masoud Amirkhalily, Lutz Gogoll, Eberhard Riedel, Armin Scherhag. (2005) Effects of Optimized Heart Failure Therapy and Anemia Correction with Epoetin &beta; on Left Ventricular Mass in Hemodialysis Patients. American Journal of Nephrology 25:3, 211-220
     

214. 214

     Masayoshi Fukui, Yasukiyo Mori, Kazuya Takehana, Hiroya Masaki, Masayuki Motohiro, Norihiko Sakamoto, Tetsuya Kitamura, Susumu Yoshida, Seishi Nakamura, Masato Baden, Mitsushige Nishikawa, Toshiji Iwasaka. (2005) Assessment of Coronary Artery Disease in Hemodialysis Patients with Delayed Systolic Blood Pressure Response after Exercise Testing. Blood Purification 23:6, 466-472
     

215. 215

     H STOPPER, N SCHUPP, A KLASSEN, K SEBEKOVA, A HEIDLAND. (2005) Genomic damage in chronic renal failure—potential therapeutic interventions. Journal of Renal Nutrition 15:1, 81-86
     

216. 216

     Gautam R. Shroff, Charles A. Herzog, Jennie Z. Ma, Allan J. Collins. (2004) Long-term survival of dialysis patients with bacterial endocarditis in the United States. American Journal of Kidney Diseases 44:6, 1077-1082
     

217. 217

     FULVIO FLOCCARI, EMANUELE ALOISI, LORENA NOSTRO, CHIARA CACCAMO, ALESSANDRA CRISAFULLI, ANTONIO BARILLA, CARMELA ALOISI, ADOLFO ROMEO, FRANCESCO CORICA, RICCARDO IENTILE, NICOLA FRISINA, MICHELE BUEMI. (2004) QTc interval and QTc dispersion during haemodiafiltration. Nephrology 9:6, 335-340
     

218. 218

     Giancarlo Marenzi, Gianfranco Lauri, Emilio Assanelli, Jeness Campodonico, Monica De Metrio, Ivana Marana, Marco Grazi, Fabrizio Veglia, Antonio L. Bartorelli. (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. Journal of the American College of Cardiology 44:9, 1780-1785
     

219. 219

     Peter A McCullough. (2004) Cardiovascular disease in chronic kidney disease from a cardiologistʼs perspective. Current Opinion in Nephrology and Hypertension 13:6, 591-600
     

220. 220

     Herwig-Ulf Meier-Kriesche, Jesse D. Schold, Titte R. Srinivas, Alan Reed, Bruce Kaplan. (2004) Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End-Stage Renal Disease. American Journal of Transplantation 4:10, 1662-1668
     

221. 221

     Rajiv Gupta, Yochai Birnbaum, Barry F. Uretsky. (2004) The renal patient with coronary artery disease. Journal of the American College of Cardiology 44:7, 1343-1353
     

222. 222

     Amparo Galán, Antonio Curós, Augusto Corominas. (2004) Interés de las troponinas en el síndrome coronario agudo en pacientes con insuficiencia renal. Medicina Clínica 123:14, 551-556
     

223. 223

     Anavekar , Nagesh S. , McMurray , John J.V. , Velazquez , Eric J. , Solomon , Scott D. , Kober , Lars , Rouleau , Jean-Lucien , White , Harvey D. , Nordlander , Rolf , Maggioni , Aldo , Dickstein , Kenneth , Zelenkofske , Steven , Leimberger , Jeffrey D. , Califf , Robert M. , Pfeffer , Marc A. , . (2004) Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction. New England Journal of Medicine 351:13, 1285-1295
     Free Full Text

224. 224

     Anupama Mohanram, Zhongxin Zhang, Shahnaz Shahinfar, William F. Keane, Barry M. Brenner, Robert D. Toto. (2004) Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney International 66:3, 1131-1138
     

225. 225

     Bruce F. Culleton, Brenda Hemmelgarn. (2004) Inadequate Treatment of Cardiovascular Disease and Cardiovascular Disease Risk Factors in Dialysis Patients: A Commentary. Seminars in Dialysis 17:5, 342-345
     

226. 226

     C. A. Herzog. (2004) Don't forget the defibrillator in the dialysis unit. Nephrology Dialysis Transplantation 19:12, 2959-2960
     

227. 227

     Vandana Menon, Mark J. Sarnak. (2004) Treating the patient with kidney failure to reduce cardiovascular disease risk. Current Treatment Options in Cardiovascular Medicine 6:4, 257-268
     

228. 228

     HONG GONG, WEIDONG WANG, TAE-HWAN KWON, THOMAS JONASSEN, CHUNLING LI, TROELS RING, JØRGEN FRØKIÆR, SØREN NIELSEN. (2004) EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney International 66:2, 683-695
     

229. 229

     M. Koch. (2004) Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study. Nephrology Dialysis Transplantation 19:10, 2547-2552
     

230. 230

     S.Susan Hedayati, Lynda Anne Szczech. (2004) The evaluation of underlying cardiovascular disease among patients with end-stage renal disease. Advances in Chronic Kidney Disease 11:3, 246-253
     

231. 231

     Ellen C Keeley, Peter A McCullough. (2004) Coronary revascularization in patients with coronary artery disease and chronic kidney disease. Advances in Chronic Kidney Disease 11:3, 254-260
     

232. 232

     Peter A McCullough. (2004) Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease. Advances in Chronic Kidney Disease 11:3, 294-303
     

233. 233

     Charles A. Herzog. (2004) Cardiac Arrest in Dialysis Patients: Taking a Small Step. Seminars in Dialysis 17:3, 184-185
     

234. 234

     Mark M. Mitsnefes, Thomas R. Kimball, William L. Border, Sandra A. Witt, Betty J. Glascock, Philip R. Khoury, Stephen R. Daniels. (2004) Abnormal cardiac function in children after renal transplantation. American Journal of Kidney Diseases 43:4, 721-726
     

235. 235

     Frederick A Masoudi, Mary E Plomondon, David J Magid, Anne Sales, John S Rumsfeld. (2004) Renal insufficiency and mortality from acute coronary syndromes. American Heart Journal 147:4, 623-629
     

236. 236

     Areef Ishani, Charles A. Herzog, Allan J. Collins, Robert N. Foley. (2004) Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect?. Kidney International 65:3, 1017-1025
     

237. 237

     W. Adam Jurewicz, Andrew Miles. (2004) Strategies for ensuring effective surveillance in post-transplant patients: practical organization and clinical evaluation. Journal of Evaluation in Clinical Practice 10:1, 37-56
     

238. 238

     Caitlin M. Nass, Kim Reck. (2004) Clinical challenges: The intersection of diabetes, chronic kidney disease, and cardiovascular disease. Current Diabetes Reports 4:1, 1-2
     

239. 239

     Andrew J. West, Simon R. Dixon, Joel K. Kahn, Robert N. Levin, William W. O'Neill, Cindy L. Grines, Aaron D. Berman. (2004) Effectiveness of primary angioplasty for acute myocardial infarction in patients on dialysis. The American Journal of Cardiology 93:4, 468-470
     

240. 240

     Hippocrates Yatzidis. (2004) Oral supplement of six selective amino acids arrest progression renal failure in uremic patients. International Urology and Nephrology 36:4, 591-598
     

241. 241

     Michelle W. Krause, Mark Massing, Abhijit Kshirsagar, Wayne Rosamond, Ross J. Simpson. (2004) Combination Therapy Improves Survival After Acute Myocardial Infarction in the Elderly with Chronic Kidney Disease #. Renal Failure 26:6, 715-725
     

242. 242

     David J. Kennedy, William R. Colyer, Pamela S. Brewster, Mary Ankenbrandt, Mark W. Burket, Attila S. Nemeth, Sadik A. Khuder, William J. Thomas, Joseph I. Shapiro, Christopher J. Cooper. (2003) Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. American Journal of Kidney Diseases 42:5, 926-935
     

243. 243

     William J. French, R.Scott Wright. (2003) Renal insufficiency and worsened prognosis with STEMI. Journal of the American College of Cardiology 42:9, 1544-1546
     

244. 244

     Madhumathi Rao, Brian J.G. Pereira. (2003) Prospective trials on anemia of chronic disease: The Trial to Reduce Cardiovascular Events with AranespR Therapy (TREAT). Kidney International 64:s87, 12-19
     

245. 245

     William A Cooper, William Brinkman, Rebecca J Petersen, Robert A Guyton. (2003) Impact of renal disease in cardiovascular surgery: emphasis on the African-American patient. The Annals of Thoracic Surgery 76:4, S1370-S1376
     

246. 246

     Eduardo Vázquez, Carmen Sánchez-Perales, Cristóbal Lozano, Ma José García-Cortés, Francisco Borrego, Manuel Guzmán, Pilar Pérez, Carlos Pagola, Ma José Borrego, Vicente Pérez. (2003) Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. The American Journal of Cardiology 92:7, 868-871
     

247. 247

     Arjang Djamali, Yolanda T. Becker, William D. Simmons, Curtis A. Johnson, Nalinee Premasathian, Bryan N. Becker. (2003) Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients1. Transplantation 76:5, 816-820
     

248. 248

     Jocelyn S Fernandez, Betty T Sadaniantz, Ara Sadaniantz. (2003) Review of antithrombotic agents used for acute coronary syndromes in renal patients. American Journal of Kidney Diseases 42:3, 446-455
     

249. 249

     Marie C Iliou, Christine Fumeron, Marie O Benoit, Philippe Tuppin, Victorio Menoyo Calonge, Nicole Moatti, Claude Buisson, Christian Jacquot. (2003) Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. American Journal of Kidney Diseases 42:3, 513-523
     

250. 250

     Ellen C Keeley, Rupin Kadakia, Sandeep Soman, Steven Borzak, Peter A McCullough. (2003) Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. The American Journal of Cardiology 92:5, 509-514
     

251. 251

     Patricia J.M Best, Ryan Lennon, Bernard J Gersh, Henry H Ting, Charanjit S Rihal, Malcolm R Bell, Charles A Herzog, David R Holmes, Peter B Berger. (2003) Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions. American Heart Journal 146:2, 345-350
     

252. 252

     Chidambaram Rammohan, Dan Fintel. (2003) Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency. Current Cardiology Reports 5:4, 303-309
     

253. 253

     Alan K Berger, Sue Duval, Harlan M Krumholz. (2003) Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. Journal of the American College of Cardiology 42:2, 201-208
     

254. 254

     J.Craig Longenecker, Josef Coresh, Santica M Marcovina, Neil R Powe, Andrew S Levey, Federico Giaculli, Nancy E Fink, Michael J Klag. (2003) Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: the choices for healthy outcomes in caring for ESRD (CHOICE) study. American Journal of Kidney Diseases 42:1, 108-116
     

255. 255

     Fernando C Trespalacios, Allen J Taylor, Lawrence Y Agodoa, George L Bakris, Kevin C Abbott. (2003) Heart failure as a cause for hospitalization in chronic dialysis patients1 1The opinions are solely those of the authors and do not represent an endorsement by the Department of Defense or the National Institutes of Health.. American Journal of Kidney Diseases 41:6, 1267-1277
     

256. 256

     Mark J Sarnak. (2003) Cardiovascular complications in chronic kidney disease. American Journal of Kidney Diseases 41, 11-17
     

257. 257

     D. N. Reddan. (2003) White blood cells as a novel mortality predictor in haemodialysis patients. Nephrology Dialysis Transplantation 18:6, 1167-1173
     

258. 258

     Simon R. Dixon, William W. O’Neill, H.Mehrdad Sadeghi, Gregg W. Stone, Bruce Brodie, David A. Cox, Eulogio Garcia, Luiz Mattos, Lorelei L. Grines, Judith A. Boura, Marie-Claude Morice, Cindy L. Grines. (2003) Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction. The American Journal of Cardiology 91:12, 1454-1457
     

259. 259

     Karin Tyralla, Kerstin Amann. (2003) Morphology of the heart and arteries in renal failure. Kidney International 63:s84, 80-83
     

260. 260

     Allan J. Collins. (2003) Cardiovascular Mortality in End-Stage Renal Disease. The American Journal of the Medical Sciences 325:4, 163-167
     

261. 261

     Christine M. Logar, Charles A. Herzog, Srinivasan Beddhu. (2003) Diagnosis and Therapy of Coronary Artery Disease in Renal Failure, End-Stage Renal Disease, and Renal Transplant Populations. The American Journal of the Medical Sciences 325:4, 214-227
     

262. 262

     Alvin H Moss. (2003) Too many patients who are too sick to benefit start chronic dialysis nephrologists need to learn to “just say no”. American Journal of Kidney Diseases 41:4, 723-727
     

263. 263

     K. Amann. (2003) Why is coronary heart disease of uraemic patients so frequent and so devastating?. Nephrology Dialysis Transplantation 18:4, 631-640
     

264. 264

     Rosario V Freeman, Rajendra H Mehta, Wisam Al Badr, Jeanna V Cooper, Eva Kline-Rogers, Kim A Eagle. (2003) Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. Journal of the American College of Cardiology 41:5, 718-724
     

265. 265

     Hiroyuki Tanaka, Takashi Narisawa, Takanobu Mori, Mikio Masuda, Daizirou Kishi. (2003) Does Myocardial Revascularization With Multiple Arterial Grafts Improve the Prognosis of Dialysis Patients?. Circulation Journal 67:10, 871-875
     

266. 266

     Donal N Reddan, John Conor O’Shea, Ian J Sarembock, Kathryn A Williams, Karen S Pieper, Edward Santoian, William F Owen, Michael M Kitt, James E Tcheng. (2003) Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). The American Journal of Cardiology 91:1, 17-21
     

267. 267

     Peter A. McCullough, Richard M. Nowak, Craig Foreback, Glenn Tokarski, Michael C. Tomlanovich, Nabil E. Khoury, W. Douglas Weaver, Keisha R. Sandberg, James McCord. (2002) Performance of Multiple Cardiac Biomarkers Measured in the Emergency Department in Patients with Chronic Kidney Disease and Chest Pain. Academic Emergency Medicine 9:12, 1389-1396
     

268. 268

     Mooyeon Oh-Park, Avital Fast, Sireen Gopal, Robert Lynn, Gil Frei, Ronald Drenth, Lenore Zohman. (2002) Exercise for the Dialyzed. American Journal of Physical Medicine & Rehabilitation 81:11, 814-821
     

269. 269

     Fernando C Trespalacios, Allen J Taylor, Lawrence Y Agodoa, Kevin C Abbott. (2002) Incident acute coronary syndromes in chronic dialysis patients in the United States1. Kidney International 62:5, 1799-1805
     

270. 270

     Allan J. Collins. (2002) Impact of congestive heart failure and other cardiac diseases on patient outcomes. Kidney International 62:s81, 3-7
     

271. 271

     Eckhart Bussemaker, Jens Passauer, Doreen Reimann, Beate Schulze, Wolfgang Reichel, Peter Gross. (2002) The vascular endothelin system is not overactive in normotensive hemodialysis patients. Kidney International 62:3, 940-948
     

272. 272

     Lawrence J Dacey, Jean Y Liu, John H Braxton, Ronald M Weintraub, Joseph DeSimone, David C Charlesworth, Stephen J Lahey, Cathy S Ross, Felix Hernandez, Bruce J Leavitt, Gerald T O’Connor. (2002) Long-term survival of dialysis patients after coronary bypass grafting. The Annals of Thoracic Surgery 74:2, 458-463
     

273. 273

     Thach Nguyen, THACH NGUYEN, SHIGERU SAITO, PHAM HOAN TIEN, CINDY L. GRINES. (2002) Fibrinolytic and Mechanical Intervention Trials in ST Elevation Acute Myocardial Infarction. Journal of Interventional Cardiology 15:4, 321-334
     

274. 274

     Robert C Kaplan, Susan R Heckbert, Curt D Furberg, Bruce M Psaty. (2002) Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. Journal of Clinical Epidemiology 55:7, 654-664
     

275. 275

     Eberhard Ritz, Ralf Dikow, Marcin Adamzcak, Martin Zeier. (2002) Congestive Heart Failure Due to Systolic Dysfunction: The Cinderella of Cardiovascular Management in Dialysis Patients. Seminars in Dialysis 15:3, 135-140
     

276. 276

     Kunitoshi Iseki, Masanobu Yamazato, Masahiko Tozawa, Shuichi Takishita. (2002) Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney International 61:5, 1887-1893
     

277. 277

     Daniel P. Tveit, Iman O. Hypolite, Paul Hshieh, David Cruess, Lawrence Y. Agodoa, Paul G. Welch, Kevin C. Abbott. (2002) Chronic dialysis patients have high risk for pulmonary embolism. American Journal of Kidney Diseases 39:5, 1011-1017
     

278. 278

     L DEMBER. (2002) Critical care issues in the patient with chronic renal failure. Critical Care Clinics 18:2, 421-440
     

279. 279

     Domenic A. Sica, Todd W.B. Gehr. (2002) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and rhabdomyolysis: considerations in the renal failure patient. Current Opinion in Nephrology and Hypertension 11:2, 123-133
     

280. 280

     Guruprasad Manjunath, Andrew S. Levey, Mark J. Sarnak. (2002) Opinion: How Can the Cardiac Death Rate be Reduced in Dialysis Patients?. Seminars in Dialysis 15:1, 18-20
     

281. 281

     Luis Gruberg, George Dangas, Roxana Mehran, Gary S. Mintz, Kenneth M. Kent, Augusto D. Pichard, Lowell F. Satler, Alexandra J. Lansky, Gregg W. Stone, Martin B. Leon. (2002) Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheterization and Cardiovascular Interventions 55:1, 66-72
     

282. 282

     Luis Gruberg, Neil J. Weissman, Ron Waksman, John R. Laird, Ellen E. Pinnow, Hongsheng Wu, Regina Deible, Kenneth M. Kent, Augusto D. Pichard, Lowell F. Satler, Joseph Lindsay. (2002) Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency. The American Journal of Cardiology 89:1, 54-57
     

283. 283

     John A. Bittl. (2001) Cardiovascular disease in dialysis patients: Double trouble. Catheterization and Cardiovascular Interventions 54:4, 464-465
     

284. 284

     K.C. Abbott, I. Hypolite, R.K. Poropatich, P. Hshieh, D. Cruess, C.A. Hawkes, L.Y. Agodoa, R.A. Keller. (2001) Hospitalizations for fungal infections after renal transplantation in the United States. Transplant Infectious Disease 3:4, 203-211
     

285. 285

     Kunitoshi Iseki, Kiyoshi Wakugami, Aiwa Maehara, Masahiko Tozawa, Hiromi Muratani, Koshiro Fukiyama. (2001) Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger. American Journal of Kidney Diseases 38:6, 1235-1239
     

286. 286

     Allan J. Collins, Shuling Li, Jennie Z. Ma, Charles Herzog. (2001) Cardiovascular disease in end-stage renal disease patients. American Journal of Kidney Diseases 38:4, S26-S29
     

287. 287

     Yoshiki Nishizawa, Tetsuo Shoji, Eiji Ishimura, Masaaki Inaba, Hirotoshi Morii. (2001) Paradox of risk factors for cardiovascular mortality in uremia: Is a higher cholesterol level better for atherosclerosis in uremia?. American Journal of Kidney Diseases 38:4, S4-S7
     

288. 288

     Michael G Shlipak, Joel A Simon, Deborah Grady, Feng Lin, Nanette K Wenger, Curt D Furberg. (2001) Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. Journal of the American College of Cardiology 38:3, 705-711
     

289. 289

     Charles A. Herzog, Fred S. Apple. (2001) Cardiac Biomarkers in the New Millennium. Seminars in Dialysis 14:5, 322-323
     

290. 290

     Jwala A Karnik, Belinda S Young, Nancy L Lew, Maureen Herget, Catherine Dubinsky, J Michael Lazarus, Glenn M Chertow. (2001) Cardiac arrest and sudden death in dialysis units. Kidney International 60:1, 350-357
     

291. 291

     Lynda Anne Szczech, Donal N Reddan, William F Owen, Robert Califf, Michael Racz, Robert H Jones, Edward L Hannan. (2001) Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney International 60:1, 292-299
     

292. 292

     Daniel Bonifacio, Krishna Malineni, Rupin Kadakia, Sandeep Soman, Keisha Sandberg, Peter McCullough. (2001) Journal of Cardiovascular Risk 8:3, 133-137
     

293. 293

     Gabriel M. Danovitch. (2001) Reduction of cardiovascular morbidity in kidney transplant recipients. Current Opinion in Organ Transplantation 6:2, 145-150
     

294. 294

     F. Gradaus. (2001) Angiographic progression of coronary artery disease in patients with end-stage renal disease. Nephrology Dialysis Transplantation 16:6, 1198-1202
     

295. 295

     Shin-ichi Osaka, Hajime Osawa, Masaaki Miyazawa, Jiro Honda. (2001) Immediate and Long-Term Results of Coronary Artery Bypass Operation in Hemodialysis Patients. Artificial Organs 25:4, 252-255
     

296. 296

     Christoph Wanner, Thomas Quaschning. (2001) Dyslipidemia and renal disease: pathogenesis and clinical consequences. Current Opinion in Nephrology and Hypertension 10:2, 195-201
     

297. 297

     Henry H. Ting, Naeem K. Tahirkheli, Peter B. Berger, James T. McCarthy, Farris K. Timimi, Verghese Mathew, Charanjit S. Rihal, David Hasdai, David R. Holmes Jr. (2001) Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. The American Journal of Cardiology 87:5, 630-633
     

298. 298

     William F. Keane, Barry M. Brenner, Arthur Mazzu, Albert Agro. (2001) The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) Protocol: A Double-Blind, Placebo-Controlled Trial in Patients With ESRD. American Journal of Kidney Diseases 37:1, S48-S53
     

299. 299

     Alice Schmidt, Thomas Stefenelli, Ernst Schuster, Gert Mayer. (2001) Informational Contribution of Noninvasive Screening Tests for Coronary Artery Disease in Patients on Chronic Renal Replacement Therapy. American Journal of Kidney Diseases 37:1, 56-63
     

300. 300

     Annamaria T. Kausz, Gregorio T. Obrador, Brian J.G. Pereira. (2000) Anemia management in patients with chronic renal insufficiency. American Journal of Kidney Diseases 36:6, S39-S51
     

301. 301

     Donal N. Reddan, Lynda Anne Szczech, Preston S. Klassen, William F. Owen. (2000) Racial Inequity in America's ESRD Program. Seminars in Dialysis 13:6, 399-403
     

302. 302

     Wilbert S Aronow, Chul Ahn, Anthony D Mercando, Stanley Epstein. (2000) Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. The American Journal of Cardiology 86:10, 1142-1143
     

303. 303

     Rosana Mussoi Bruno, Jorge Luiz Gross. (2000) Prognostic factors in Brazilian diabetic patients starting dialysis. Journal of Diabetes and its Complications 14:5, 266-271
     

304. 304

     Michael L Picton, Robert N Foley. (2000) Reducing cardiovascular morbidity and mortality from hypertension in end-stage renal disease. Current Opinion in Nephrology and Hypertension 9:5, 497-500
     

305. 305

     Dion L Franga, John M Kratz, A.Jackson Crumbley, James L Zellner, Martha R Stroud, Fred A Crawford. (2000) Early and long-term results of coronary artery bypass grafting in dialysis patients. The Annals of Thoracic Surgery 70:3, 813-818
     

306. 306

     Peter A McCullough, Sandeep S Soman, Shalin S Shah, Stephen T Smith, Keisha R Marks, Jerry Yee, Steven Borzak. (2000) Risks associated with renal dysfunction in patients in the coronary care unit. Journal of the American College of Cardiology 36:3, 679-684
     

307. 307

     Sophia Zoungas, Sonya Ristevski, Paul Lightfoot, Yu-Lu Liang, Pauline Branley, Louise M Shiel, Peter Kerr, Robert Atkins, John J McNeil, Barry P McGrath. (2000) Carotid Artery Intima-Medial Thickness Is Increased In Chronic Renal Failure. Clinical and Experimental Pharmacology and Physiology 27:8, 639-641
     

308. 308

     Paul T. Vaitkus. (2000) Current status of prevention, diagnosis, and management of coronary artery disease in patients with kidney failure. American Heart Journal 139:6, 1000-1008
     

309. 309

     Mark J. Sarnak, Andrew S. Levey. (2000) Cardiovascular disease and chronic renal disease: A new paradigm. American Journal of Kidney Diseases 35:4, S117-S131
     

310. 310

     Francesco Locatelli, Daniele Marcelli, Ferruccio Conte, Lucia Del Vecchio, Aurelio Limido, Fabio Malberti, Donatella Spotti, Sergio Sforzini, for the Registro Lombardo Dialisi e. (2000) Patient selection affects end-stage renal disease outcome comparisons. Kidney International 57:s74, 94-99
     

311. 311

     Nelson Mazzuchi, Juan M. Fernandez-Cean, Enriqueta Carbonell. (2000) Criteria for selection of ESRD treatment modalities. Kidney International 57:s74, 136-143
     

312. 312

     G. M. Chertow. (1999) Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients. Nephrology Dialysis Transplantation 14:12, 2907-2914
     

313. 313

     Daylily S Ooi, John P Veinot, George A Wells, Andrew A House. (1999) Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. Clinical Biochemistry 32:8, 647-652
     

314. 314

     Sabine Wessels, Kerstin Amann, Johannes Törnig, Eberhard Ritz. (1999) Cardiovascular Structural Changes in Uremia: Implications for Cardiovascular Function. Seminars in Dialysis 12:5, 288-292
     

315. 315

     Charles A. Herzog. (1999) Cardiovascular Disease and Dialysis Patients: Is Therapeutic Nihilism Justified?. Seminars in Dialysis 12:5, 285-287
     

316. 316

     Chi-Ling Hang, Mien-Cheng Chen, Bao-Jueng Wu, Chiung-Jen Wu, Sarah Chua, Morgan Fu. (1999) Short- and long-term outcomes after percutaneous transluminal coronary angioplasty in chronic hemodialysis patients. Catheterization and Cardiovascular Interventions 47:4, 430-433
     

317. 317

     Christoph Wanner, Vera Krane, Gunther Ruf, Winfried Marz, Eberhard Ritz. (1999) Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Kidney International 56:S71, 222-226
     

318. 318

     Charles A. Herzog. (1999) Acute myocardial infarction in patients with end-stage renal disease. Kidney International 56:S71, 130-133
     

319. 319

     Keiko Oi, Tsutomu Hirano, Soichi Sakai, Yoshindo Kawaguchi, Tatsuo Hosoya. (1999) Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney International 56:S71, 227-228
     

320. 320

     Charles A Herzog, Jennie Z Ma, Allan J Collins. (1999) Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney International 56:1, 324-332
     

321. 321

     Alan B Storrow, W.Brian Gibler. (1999) The role of cardiac markers in the emergency department. Clinica Chimica Acta 284:2, 187-196
     

322. 322

     (1999) Briefly Noted. Seminars in Dialysis 12:3, 209-210
     

323. 323

     Robert M. Brenner, Elizabeth M. Wrone. (1999) The epidemic of cardiovascular disease in end-stage renal disease. Current Opinion in Nephrology and Hypertension 8:3, 365-369
     

324. 324

     Andrew G. Bostom, Bruce Culleton. (1999) Hyperhomocysteinemia in Chronic Renal Disease: Potential Relevance to Arteriosclerosis. Seminars in Dialysis 12:2, 103-111
     

325. 325

     Eduardo K. Lacson Jr., William F. Owen Jr.. (1999) CARDIAC DISEASE IN DIALYSIS PATIENTS: Interactions Between Hemodialysis Adequacy and Nutrition in Dialysis Patients. Seminars in Dialysis 12:2, 112-116
     

326. 326

     Luke , Robert G. , . (1998) Chronic Renal Failure — A Vasculopathic State. New England Journal of Medicine 339:12, 841-843
     Full Text